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The advancement of sequencing technology has provided a renewed appreciation 
for the diversity of life on earth with most environments being dominated by yet-uncultured 
microorganisms. Analysis of 16S rRNA gene sequencing libraries of the original Human 
Microbiome Project dataset revealed that approximately 70% of sequences belonged to 
bacteria that were uncultured in the laboratory and current metagenomic analysis of the 
human microbiome has proposed 77% of taxa lacked sequenced genomes. As the 
human microbiome is important for healthy host physiology, these findings emphasize 
just how little we currently know about the microorganisms that reside in the human body. 
Understanding the microorganisms that make up the normal human microbiome is the 
first logical step in determining, during dysbiosis and disease, how the community 
changes as a whole so as to permit investigation into preventative and/or treatment 
measures during disease. For example, many disease-associated lineages of bacteria in 
periodontal disease remain uncultured in the laboratory and therefore limited insight is 
available as to whether or not these organisms play a role in disease etiology or their 
presence is a secondary effect of the disease state. Therefore, cultivating more 
microorganisms from the human microbiome is critical as it enables hypothesis-driven 
experimentation into the roles of those organisms in human health and disease. The work 
presented here represents a two-fold approach for cultivation of bacteria from the human 
oral microbiome by both classical means and by the development of a novel, “reverse-
genomics” approach. First, I identified a specific interaction between Desulfobulbus oralis 
and Fusobacterium nucleatum that resulted in the isolation of the first Desulfobulbus 
genus member from the human oral cavity and I characterized this bacterium both 
physiologically and genomically. Next, I investigated what causes the recalcitrance of 
some oral bacteria to cultivation and what contributes to their dependence on other 
bacteria, such as F. nucleatum. Lastly, we leveraged existing public sequence data to 
target specific TM7 bacteria from within the microbial community for both single-cell 
genomic characterization and cultivation. Collectively this work demonstrates how 
cultivation-dependent and cultivation-independent methodology can be combined to 
investigate the “dark microbial matter” in the human oral cavity.  
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 Portions of this introduction will be submitted as part of a mini-review for the journal 
Environmental Microbiology. Mircea Podar was invited for the review and all material 
contained within this chapter was written by K.L.C. 
 
The Human Microbiome and Uncultured Bacteria 
Microbes have been evolving for billions of years on Earth, well before the 
emergence of primates. Humans have co-evolved with our microbial counterpart – the 
human microbiome (1, 2). We may begin acquiring our microbiome even before birth (3-
5) and homeostasis with our microbiota is pertinent to our health (6). Soon after the 
Human Genome Project was completed, the Human Microbiome Project (HMP) was 
conceptualized. The HMP sought to identify all of the microorganisms residing in/on the 
healthy human body so as to lay the groundwork for understanding, in part, their 
ecological roles in human health and disease (1). Using metagenomics and 16S rRNA 
gene analysis, the HMP began to elucidate the vast diversity of microorganisms in the 
human microbiome and identified specific groups of microorganisms dominating different 
niches (2). In doing so, a large collection of microbial reference genomes was produced 
that further exemplified just how little we may know about the microorganisms that live 
in/on the human body. These analyses have provided a robust baseline for what may 
constitute a healthy human microbiome and has set the stage for further studies looking 
at microbiome variations during different human states and diseases.  
A healthy microbiome is important, in part, for to its abilities to provide inaccessible 
nutrients for host consumption and to provide a line of defense against foreign invaders. 
The field of clinical microbiology began with the culturing of microorganisms from the 
human body. Historically, the main focus was on microorganisms that cause disease, 
which led to Koch’s postulate by which a pathogen must be isolated from a sick individual 
to be deemed the causative agent of a disease. This resulted in the development of media 
that supported growth of such pathogens. Conversely, when microorganisms were 
cultured from the environment, such media did not necessarily work due to organisms 
having different metabolic requirements and growth dynamics. By implementing new 
methods, such as the Winogradsky column, more diverse organisms could be cultured. 
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Recently we have begun to appreciate this in regard to understanding the microorganisms 
of the human microbiota, as 16S rRNA gene-based studies have correlated native 
microbial species to human disease with many being currently uncultured in the 
laboratory by standard culturing techniques (i.e. periodontitis (7)).  
Preliminary analysis in 2012 by Fodor et al. of the HMP dataset identified about 
70% of OTUs belonged to “uncultured” or “clone” designations (8). They further ranked 
OTUs as “most wanted” for whole genome sequencing and/or cultivation if they had less 
than 90% identity (16S rRNA gene V1-V3 and V3-V5 regions) to those existing in the 
GOLD-Human or HMP databases and noted that only between 1.7% and 10% of total 
HMP OTUs belonged to this “most wanted” list (8). It became evident that the human host 
harbors numerous uncultured microorganisms, however few belong to those 
phylogenetically novel bacterial lineages. More recent database mining at the 16S level 
has suggested between 45%-97% of human microbiome taxa may, in fact, be cultured 
(9). The advancement of sequencing and binning technology for metagenomics has 
currently allowed us to move away from just 16S gene level analysis and take the whole 
genome into consideration, which is important when considering the difficulty in assigning 
species and strain level taxonomy (10). A recent metagenomics analysis of over 150,000 
metagenomes from the human microbiota identified 77% of their metagenome-
assembled genomes (MAGs) previously belonged to microorganisms with no available 
genomes (either WGS of isolates or MAGs) (11). While great strides have been made in 
understanding “who is there” in the human microbiome, the physiology of most microbes, 
their interactions with each other, and their impact on human health and disease are just 
beginning to be uncovered. More reference genomes, and most importantly more cultured 
representatives, are required to advance from mere associations-based inferences so as 
to permit hypothesis driven experimentation at the interface of human health and disease.  
 
The Oral Microbiome and Oral Diseases 
In 2010, the Human Oral Microbiome Database (HOMD) was created, relying 
primarily on 16S rRNA gene sequences from clone libraries, that provides a 
comprehensive database to house phylogenetic and genomic information pertaining to 
the plethora of bacteria that reside in the oral cavity (12). At the time there was an 
 
 4 
estimated 619 bacterial taxa from 13 phyla making up the human oral microbiota, 96% of 
them belonging to just 6 phyla, with approximately 34% of total taxa being uncultured (12, 
13). Currently, the HOMD houses reference information for 770 microbial species and 
has been expanded (eHOMD) to also include microorganisms of the human aerodigestive 
tract (14). Of these approximately 770 microbial species, 62% have genomic data 
available, however 30% remain as uncultivated phylotypes in the oral cavity 
(www.homd.org v14.51)(14). There is still much to learn as to why these microorganisms 
remain uncultured and what role those microorganisms play in human health and disease.  
Periodontitis is a common disease that results from host inflammatory responses 
to native oral bacteria (7, 15, 16) and has a complex etiology originating from within the 
human oral microbiome as a result of synergistic and dysbiotic interactions between 
members of the microbial community (17, 18). This inflammation results in swelling or 
bleeding of the gums, tooth loss, and bone and tissue loss (7, 19). The exact etiology of 
periodontal disease remains unclear due to the complexity of the changing oral microbial 
community (20). Specifically, periodontal diseases do not arise from a single, easily 
detectable pathogen but rather as a result of a native community shift favoring keystone 
species (21). These species are capable of provoking a proinflammatory response that 
can further alter the community and lead to dysbiosis (21).  
The oral cavity provides a variety of niches, such as saliva, supragingival, and 
subgingival locations, for the growth of distinct organisms with varying metabolic 
requirements (i.e. aerobes vs. anaerobes) (22).  In 2012, Griffen et al. used 454 
pyrosequencing to compare the subgingival microbial community between healthy and 
chronic periodontal patients to understand how the microbial community may change as 
a result of disease (7). They discovered that 53 microbial species were significantly more 
abundant in health while 123 species were more abundant in disease (7). Of those 
identified to associate with disease, over half were currently uncultured, with entire phyla 
existing with no cultured representatives at the time (7). Likewise, using Illumina 
sequencing of 16S rRNA gene libraries of the subgingival microbiome, eight specific 
classes of bacteria were correlated with periodontitis including Chloroflexi, 
Deltaproteobacteria, Spirochaetes, and Synergistetes (23), each encompassing yet-
cultured representatives (7). In addition to periodontal disease, another common disease 
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is dental caries which results in dental demineralization. A survey of the supragingival 
microbiome of twins with and without caries identified uncultured bacteria from the 
candidate phyla TM7 and GN02 present in the samples with a particular uncultured TM7 
bacterium correlating with taxa associated with caries-positive subjects (24).    
 
Cultivation-independent Studies 
Although 16S rRNA gene studies can give us an idea about “who is there”, next-
generation sequencing provides a more comprehensive genomic analysis where we can 
begin to make inferences about what these microorganisms may be doing based on their 
genomic content. Two methods to sequence the genomes of currently uncultured 
microorganisms from within complex microbial communities is by single-amplified 
genomics (SAGs) and metagenomic-amplified genomics (MAGs). Each approach has 
pros and cons and it ultimately depends on the research question being asked as to which 
approach works best for which situation (reviewed in (25, 26)). One benefit of SAGs is 
that the approach can be more targeted towards organisms of interest. Further, since 
sequenced DNA is from a single cell, this method provides species/strain level resolution 
(25, 26). Conversely, due to amplification bias associated with SAGs, MAGs tend to 
provide a more complete genome with even sequencing coverage as well as the 
opportunity to provide a larger microbiome-wide look at the genomic content of each 
sample set (25).  
An interesting group of microorganisms that reside in the human oral microbiota 
belong to the “candidate phyla radiation” (CPR) (27), which includes TM7, GN02, and 
SR1 bacteria, deep-branching uncultured lineages. Single-cell genomics provided an 
initial view into some of these organisms in the oral cavity. The first genomic information 
for TM7 came from single-cell genomes in 2007 in which the phrase microbial “dark 
matter” was first coined (28). An early 16S rRNA gene clone study had previously 
investigated TM7 diversity in the human oral cavity (29) and found that TM7 rRNA gene 
abundance was higher in patients exhibiting periodontal disease, relative to total bacterial 
rRNA, with a specific TM7 subgroup being detected more in diseased than in healthy sites 
(29). That first glimpse at the genomic information contained within a TM7 genome 
generated initial hypotheses as to the metabolic potential for TM7 bacteria in the oral 
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cavity and recognition that they encoded Type IV secretion systems (28, 30, 31). 
Furthermore, a single-cell genome of an oral SR1 bacterium identified that this particular 
group of organisms harbored a unique genetic code by recoding the traditional UGA stop 
codon as a glycine (32). 
In addition to phylogenetically novel microorganisms, single-cell genomics has 
helped elucidate the potential roles other uncultured disease-associated lineages of 
bacteria may play in the oral cavity. As stated previously, 16S rRNA gene studies revealed 
correlations between Deltaproteobacteria and Chloroflexi with periodontal disease (7, 
23). Further single-cell genomic sequencing of these groups of organisms provided novel 
insights into their host adaptation and a putative role in disease and also provided 
hypotheses for cultivation in the laboratory (33, 34). Uncovering information about 
disease-associated microorganisms via single-cell genomics has been useful in 
furthering our understanding of health-associated species, as is the case with a previously 
uncultured health-associated Tannerella species (35).  
As periodontal disease and caries have a polymicrobial etiology, metagenomic 
studies can resolve community-wide genomes to provide further insights into the whole 
community’s functional potential (36). One of the first metagenomic studies to look at the 
differences in community composition in oral health and disease was in 2012. This study 
demonstrates that healthy individuals (those who had never suffered from dental caries) 
were significantly enriched in certain functions relating to antimicrobial peptides and 
quorum sensing (36). Based on that, it was hypothesized that some of the health-
associated oral bacteria, specifically some streptococci, could act as “probiotics” by 
having an antagonistic effect on cariogenic bacteria (36). This led to cultivation of 249 
isolates from healthy individuals, of which 16 were capable of inhibiting the growth of 
cariogenic bacteria, most being closely related to Streptococcus oralis, S. mitis, and S. 
sanguis (36).  
 Single-cell genomes and metagenomes can reveal the physiological potential of a 
microorganism, but the functions encoded in genomes are not always expressed at either 
the RNA or protein level. Further cultivation-independent approaches can harness 
technologies such as transcriptomics and proteomics to measure the relative abundance 
of mRNA transcripts or proteins which can serve as a representation of the metabolic 
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activity of specific organisms or the microbial community as a whole. As noted in the 
original HMP dataset, microbial community structure can change considerably in healthy 
individuals but on a functional level may remain consistent (6). A more robust analysis of 
the human oral microbiome using metatranscriptomics revealed that periodontal patients 
displayed conserved metabolic profiles during disease (37). Specifically, gene expression 
relating to lysine fermentation to butyrate and pyruvate fermentation were significantly 
more expressed in all diseased sites indicating that these functions may be important for 
influencing disease-associated microbial communities (37). RNAseq further provided 
species-level resolution and revealed that Fusobacterium nucleatum was responsible for 
lysine degradation to butyrate in those individuals, despite no significant change in F. 
nucleatum rRNA abundance, indicating that a shift in gene expression by specific 
organisms may contribute to the changing environment that results in oral diseases (37). 
Similarly, specific metabolic changes occur within the microbial community during the 
onset of gingivitis in which the community favors genes involved in pathways such as 
propanoate and butanoate metabolism (38).  
Although the information gained from sequencing studies can provide useful 
insight into the functions of the human microbiota, it still remains a bioinformatics end-
point. Further cultivation of currently uncultured bacteria can fuel hypothesis-driven 
studies about the role these microorganisms play in their environments. Isolation enables 
us to advance from disease correlations to understanding etiology and specific 
pathogenicity mechanisms so that effective treatment can be achieved. 
 
Cultivation-dependent Studies 
Some periodontal pathobionts have been identified but many disease-associated 
lineages remain uncultured (17). With the 770 bacterial taxa identified in the human oral 
cavity, 1/3rd represent yet-cultivated members (12, 13). Their recalcitrance to culturing 
under standard culture methods may be due to their dependencies on co-evolving 
bacterial community members, an idea supported by recent advances in culturing such 
organisms. For example,  Fretibacterium fastidiosum (phylum Synergistetes) is 
dependent upon Fusobacterium nucleatum for growth in pure culture (39). Another 
example is cultivation of a human health-associated Tannerella species (40), first 
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characterized by single-cell genomics (35). That isolate, Tannerella BU063, requires 
‘helpers’ such as Prevotella intermedia or Propionibacterium acnes to stimulate growth, 
with colonies of BU063 forming satellites around other oral species (40). Likewise, the 
first oral bacterium cultured from the phylum Chloroflexi, Chloroflexi taxon Anaerolineae 
bacterium HOT439, requires ‘helper’ bacteria, including F. nucleatum, for growth (41) and 
was isolated by adding siderophores to culture medium (41). These findings suggest a 
reliance of these organisms on a community lifestyle, where species interact and may 
depend upon each other, an aspect that needs to be considered when designing 
cultivation experiments. 
In some instances, catering media variations to specific growth requirements 
enables successful cultivation of previously uncultured microorganisms (42, 43). 
Traditional media (such as LB or BHI) used to culture bacteria does not support the growth 
of a high diversity of oral bacteria (43). However, if steps are taken to develop a medium 
that meets the nutritional requirements of more diverse oral microorganisms then perhaps 
more organisms may be brought into culture. One such success is the development of 
“SHI medium” that supports the growth of high percentages of uncultured oral bacteria 
(43). Similarly, longer-term anaerobic cultivation aimed at identifying slow-growing and/or 
satellite colonies on diverse media arrays was successful in isolating novel Bacteroidetes, 
Lachnospiraceae and Clostridiales species (42).   
 Bacteria from the candidate TM7 phylum (more recently renamed 
“Saccharibacteria”(44)) have been recalcitrant to cultivation for many years. The first 
representative to be cultured, “TM7x,” was isolated from the human oral cavity in 2015 
(45). TM7x is an obligate epibiotic parasite on Actinomycetes odontolyticus XH001 (45, 
46), confirming earlier hypotheses that these organisms may be heavily reliant on others 
for growth (47). TM7x masks a proinflammatory response when incubated with its host 
and bone marrow macrophages, as compared to host alone, and enhances biofilm 
formation when grown with its host (45, 48).  
 In addition to traditional approaches for culturing novel microorganisms of the 
human oral cavity, newer technologies have emerged to facilitate further cultivation of the 
uncultured. Many organisms in the human oral cavity have a biofilm lifestyle where 
species grow and interact in complex ways resulting in strict interdependencies where 
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growth may only occur in a community (49, 50). In-vitro biofilm models can be employed 
to grow stable, reproducible, communities that harbor uncultured microorganisms. One 
such example resulted in the growth of 51 uncultured oral taxa including a TM7 (51).  
Another example is the use of microfluidics, microdroplets, and artificial teeth to simulate 
the natural environment and allow species to interact as they would in the oral cavity to 
support their growth (52-54).  
 
Sulfate Reducing Bacteria  
As periodontitis leads to the formation of deep subgingival pockets, this allows 
proliferation of anaerobic microorganisms. Sulfate-reducing bacteria (SRB) have been 
detected in periodontal pockets (55) and implicated in other diseases such as ulcerative 
colitis (56). Inherently SRB could be involved in such destructive diseases due to the 
effects of their metabolic by-products (33, 57) such as hydrogen sulfide that results from 
dissimilatory sulfate reduction. SRB are not abundant members of the oral microbial 
community, with the most common being species of Desulfovibrio. Isolates of 
Desulfovibrio fairfieldensis have been associated with periodontitis (55) while culture-
independent studies have linked the SRB genus Desulfobulbus with periodontal disease 
in the oral cavity (23, 58, 59).  
Approximately eleven environmental Desulfobulbus species have been isolated 
and formally characterized to date (60-67). A single Desulfobulbus OTU exists within the 
human oral cavity (HOT041). It is generally present at abundances below 1% of the total 
microbial community (7, 58) but in periodontitis can reach levels as high as 2% (58). 
Environmental Desulfobulbus species are of particular interest due to their ability to 
methylate mercury producing a powerful neurotoxin (68). Should oral Desulfobulbus 
HOT041 be able to produce methylmercury this could have significant health implications. 
Cultivation of host-associated Desulfobulbus and its comparison to environmental 
Desulfobulbus would provide important insights into the evolution of this genus and in 
identifying whether anaerobic sulfate-reducers merely persist in disease sites or are 




Candidate Phylum TM7 Bacteria 
As mentioned previously, the human oral cavity is home to three candidate phyla 
lineages of bacteria: TM7, GN02, and SR1. The TM7 phylum (Candidate Division 
Saccharibacteria) is ubiquitous and is found in environments ranging from arctic regions 
(69), sediments (47, 70), wastewater (71), bioreactors (44, 72, 73), and the human body 
(28, 29, 45, 74, 75). The first identification of this bacterium was in 1996 when clone 
sequences were prepared from a peat bog in Germany (76, 77). However, their clone 
‘TM7’ represented a solitary deep rooting phylogenetic lineage and no inferences could 
be made concerning its role in the environment. Hugenholtz et al. performed the first 
targeted study of the TM7 phylum in 2001 (73) in which they used new and existing 16S 
rRNA gene sequences from environmental samples to garner a more robust phylogenetic 
analysis of these bacteria. This study greatly expanded our view of TM7 phylogeny (73). 
The TM7 phylum still remains an enigmatic lineage of bacteria to this day with slow strides 
being made in their study. 
Recently, deep-sequencing community analysis revealed TM7 bacteria to be 
enriched in disease samples relative to non-disease samples. Further genomic 
investigation identified potential virulence factors encoded in TM7 genomes, connecting 
genotype to a potential disease function (78). Generally present at below 1% of the 
healthy oral community (29, 70), TM7 abundance can increase in periodontal bacterial 
communities (29, 78). The advancement of whole genome sequencing has continued to 
provide a more robust look at TM7 bacteria (28, 70), identifying over a dozen lineages of 
TM7 in the oral cavity and noting the average size of TM7 genomes being close to the 
lower limit of life for free-living bacteria (44). Partial and completed TM7 genomes (28, 
70) seem to suggest TM7 have limited metabolic potential even in free-living 
environments. Genome streamlining and reduction can occur as bacteria transition from 
free-living to host-associated environments. This often results in restricted host range and 
in some cases the acquisition of pathogenicity traits (79-81), but limited knowledge can 
be acquired from just sequencing analysis alone. More unique genomes representing 
specific and diverse OTUs from host-associated environments are desirable and without 
more cultured representatives, TM7 adaptation to the oral cavity and potential role in 
disease remains unknown.   
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Non-bacterial Diversity of the Human Oral Cavity 
 Many studies have focused on the highly diverse communities of bacteria that 
reside in the human microbiota. However, all branches of life are present including fungi, 
archaea, and viruses. This varies by body site where some specialized niches may harbor 
none (i.e. subgingival microbiome (24)). Of the HMP dataset, only 0.01% of sequences 
aligned to fungal genomes (82). The most abundant fungi identified in human stool 
samples is Saccharomyces (82) while for the skin it is Malassezia (83), and for the oral 
and vagina it is Candida (84, 85). Many fungi from the human microbiome have cultured 
representatives at the genus level but cultivation of these different groups is inconsistent 
due to variability regarding which species colonize which individuals and their potential 
transience (82). For example, in 2010 one of the first studies to look at uncultured fungi 
within the oral cavity identified 74 culturable and 11 non-culturable fungal genera (85). 
However 39 genera occurred only once among the 20 patients analyzed emphasizing 
how much variability occurs between individuals (85). Continued advancement in 
metagenomics and single-cell genomics can aid in further exploration of fungi that lack 
uncultured or unsequenced relatives (86, 87).  
 Archaea are an even more underexplored component of the human microbiome; 
with many uncultured representatives and none known to cause disease, although some 
associations have been made (88). The most abundant archaea detected and perhaps 
the best studied, are the methanogenic archaea (89) hypothesized to be keystone 
species that play crucial roles in overall community composition (reviewed in (90)). Of the 
methanogenic archaea, five have been isolated from either fecal samples or the oral 
cavity (90). Methanobrevibacter oralis is the most dominant oral archaeon (91). 
Methanogenic archaea form syntrophic relationships with other bacteria and these 
interspecies dependencies may result in the recalcitrance of other bacteria that depend 
on archaeal partner metabolic byproducts for their own metabolism (91). Despite some 
progress made in the cultivation of archaea, there is much unexplored diversity to still 
uncover. 
Perhaps the most difficult components of the human microbiome to study is the 
viral portion (or the virome) in part because of the lack of common markers for viruses, 
the variability in their genomic content (i.e. DNA vs RNA viruses), and limited reference 
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material. The human microbiome harbors an estimated number of 10 viruses for every 1 
bacterial cell (92), with many viruses residing in the oral cavity, gut, vagina, and skin. The 
majority are bacteriophages (93-96). The skin and oral cavity have relatively stable 
viromes (94, 95) rather than being highly transient at these exposed locations. Such 
sequencing analyses can detect virus-like-particles and provide insight into possible 
functions of the virus community.  
As we continue to learn more about the bacterial portion of the human microbiome, 
we further appreciate the tight communities they form with each other as well as how their 
interactions with fungi, archaea, and viruses may help shape their interactions with the 
human host. More work is required to fill databases and culture collections to continue to 
advance our understanding of the diverse microorganisms of the human microbiome. As 
cultivation-dependent and -independent approaches continue to advance, no branch on 
the tree of life may remain untouched.  
 
Research Objectives 
 Despite advances in both cultivation-independent and cultivation-dependent 
studies of the human microbiome, many microorganisms remain uncultured. This results 
in a lack of hypothesis-driven experimentation regarding their role in human health or 
disease. The work described in this dissertation collectively aims to overcome this barrier 
and bring previously uncultured microorganisms into laboratory cultures by refining 
traditional methodologies and also developing new approaches (Figure 1.1).  
 In Chapter 2 I aimed to isolate and characterize the human oral Desulfobulbus, a 
sulfate reducing bacterium for which single cell genomic data were previously obtained in 
our laboratory (33). This particular organism has been linked to periodontal disease and 
single-cell genomic analysis has identified potential virulence factors that may play a role 
in disease progression. Oral Desulfobulbus has evaded cultivation and it has been 
unknown whether this bacterium merely persists in subgingival pockets or actively 
contributes to a proinflammatory environment. Chapter 2 describes the isolation and 
characterization of Desulfobulbus oralis sp. nov. and provides evidence of the potential 







Figure 1.1. Graphical abstract outlining cultivation-dependent and cultivation-
independent approaches for the study of human microbiome samples. Methods such as 
single cell genomics and metagenomics can elucidate the potential functions 
microorganisms have in their environments (left) and can be used to formulate 
hypotheses about how to culture them. Coupling this with traditional microbiology (right) 
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During the isolation of D. oralis in Chapter 2, I uncovered clues as to why this 
organism has been recalcitrant to cultivation. D. oralis is dependent on Fusobacterium 
nucleatum by-products for growth. Chapter 3 investigates this dependency by using 
metabolomics facilitated by mass spectrometry to understand the metabolic by-products 
of F. nucleatum. As other bacteria have been shown to also have this dependency, 
identifying metabolites produced by F. nucleatum may assist in the cultivation of other 
currently uncultured microorganisms of the human microbiome.    
 Finally, to begin to understand other oral lineages that lack cultured 
representatives, Chapter 4 details a “reverse-genomics” cultivation approach using TM7 
bacteria as a test case. TM7 bacteria are phylogenetically diverse in the oral cavity (over 
a dozen distinct OTUs) with only one representative cultured to date (a single Group 1 
TM7 out of the 6 identified clades).  We demonstrate the utility of this approach by 















CHAPTER TWO - Insights into the evolution of host association 
through the isolation and characterization of a novel human 
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Abstract 
The human oral microbiota encompasses representatives of many bacterial 
lineages that have not yet been cultured. Here we describe the isolation and 
characterization of previously uncultured Desulfobulbus oralis, the first human-associated 
representative of its genus. As mammalian-associated microbes rarely have free-living 
 
 17 
close relatives, D. oralis provides opportunities to study how bacteria adapt and evolve 
within a host. This sulfate-reducing deltaproteobacterium has adapted to the human oral 
subgingival niche by curtailing its physiological repertoire, losing some biosynthetic 
abilities and metabolic independence, and by dramatically reducing environmental 
sensing and signaling capabilities. The genes that enable free-living Desulfobulbus to 
synthesize the potent neurotoxin methylmercury were also lost by D. oralis, a notably 
positive outcome of host association. However, horizontal gene acquisitions from other 
members of the microbiota provided novel mechanisms of interaction with the human 
host, including toxins like leukotoxin and hemolysins. Proteomic and transcriptomic 
analysis revealed that most of those factors are actively expressed, including in the 
subgingival environment, and some are secreted. Similar to other known oral pathobionts, 
D. oralis can trigger a pro-inflammatory response in oral epithelial cells, suggesting a 
direct role in the development of periodontal disease. 
 
Importance 
Animal-associated microbiota likely assembled as a result of numerous 
independent colonization events by free-living microbes followed by co-evolution with 
their host and other microbes. Through specific adaptation to various body sites and 
physiological niches, microbes have a wide range of contributions, from beneficial to 
disease causing. Desulfobulbus oralis provides insights into genomic and physiological 
transformations associated with transition from an open environment to a host-dependent 
life style and the emergence of pathogenicity. Through a multi-faceted mechanism 
triggering pro-inflammatory response, D. oralis is a novel periodontal pathobiont. Even 
though culture-independent approaches can provide insights into the potential role of the 
human microbiome “dark matter”, cultivation and experimental characterization remain 
important to studying of the roles of individual organisms in health and disease.   
 
Introduction 
Periodontitis is one of the most prevalent human diseases around the world. 
Moderate stages affect more than half of adults while the severe form, involving tooth 
loss, occurs in 10-20% of the population (97, 98). Periodontitis has a complex 
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polymicrobial etiology with current models implicating synergistic and dysbiotic 
interactions between members of the gingival microbial community (including species 
present at low abundance) as the disease onset (16, 21, 99, 100). Plaque biomass 
accumulation followed by changes in the composition of the microbiota lead to and 
advance gum inflammation (gingivitis). Further increase in microbial biomass, 
exacerbated by poor hygiene and genetic predisposition sustain additional shifts in the 
microbial community composition, which becomes increasingly anaerobic in deepening 
periodontal pockets as periodontitis develops (100). At that stage, microbial signaling, 
with some species playing keystone disease roles, interferes with the normal host 
immune defense and causes a persistent inflammatory response, resulting in tissue and 
bone loss (101, 102). 
Among the first bacteria implicated in the etiology of periodontal disease were 
Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia (103). More 
recent microbiome sequencing and disease association studies suggest that a much 
larger number of species (from over 700 that constitute the human oral microbiome) likely 
play a role in the development of oral disease, highlighting that periodontitis has a 
complex, polymicrobial etiology (20, 78, 104, 105). Some species are potentially 
beneficial, contributing to a healthy oral homeostasis, while others are associated with 
various stages of gingivitis and periodontitis, potentially acting as keystone species and/or 
virulent components of the disease-inducing microbiota (100). Studies with pure cultures, 
defined communities in vitro and in animal models have revealed pro-inflammatory 
characteristics and interspecies signaling that result in community shifts and a host 
response leading to tissue destruction (106, 107). However, approximately one-third of 
the oral microbial species-level taxa are still uncultured, including dozens of disease-
associated lineages (108). To better understand the complex interactions between oral 
bacteria and their role in the transition from health to disease, cultivation remains a critical 
initial step (108). 
Based on rRNA relative sequence abundance, Desulfobulbus sp. HOT41 
(Deltaproteobacteria) has been one of the uncultured bacteria strongly associated with 
advanced periodontitis (104, 105). Deltaproteobacteria have low taxonomic diversity in 
the human microbiome and other species have been linked, based on relative 
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abundance, to either oral disease (Desulfomicrobium orale and Desulfovibrio 
fairfieldensis) (109, 110) or to intestinal and gynecological disorders (Desulfovibrio piger 
and Desulfovibrio intestinalis) (111-113). As with other oral species, it has remained 
unclear if those organisms play a role in the etiology of periodontitis or their increased 
abundance is a consequence of the disease state, with deep subgingival pockets favoring 
the proliferation of strict anaerobes. No host-associated species of Desulfobulbus has 
been cultivated so far, although multiple free-living relatives have been isolated and 
characterized from aquatic and sediment samples (60-62, 65-67, 114). All free-living 
Desulfobulbus species are sulfate reducers, strict anaerobes, largely prototrophic, and 
use a variety of electron donors and acceptors. Adaptation to a host-associated lifestyle 
provides relative environmental stability and close interaction with other host-recruited 
species. These factors often lead to genome reduction, metabolic co-
dependence/specialization, and sometimes emergence of pathogenicity through lateral 
gene transfer (114-116).  Previous single-cell genomic data suggested Desulfobulbus sp. 
HOT41 is capable of sulfate reduction (33), which we used here to selectively enrich for, 
isolate, and characterize that organism as the first host-associated member of the 
Desulfobulbus genus. Its physiological, genomic, and immune modulatory characteristics 
provide new insights into adaptation to the human host-associated lifestyle and the 
emergence of pathogenicity.  
 
Results and Discussion 
Enrichment cultures and isolation of a human oral Desulfobulbus in pure 
culture. We established culture enrichments of sulfate-reducing bacteria using human 
oral subgingival samples collected from an individual with chronic periodontitis. Upon 
repeated passage in sulfate-lactate based medium we obtained a stable, simple 
community composed of Fusobacterium nucleatum, a common human oral bacterium, 
and Desulfobulbus sp. HOT41. The composition of this co-culture was characterized 
using small subunit rRNA amplicon sequencing (Illumina MiSeq), fluorescence in situ 
hybridization (FISH), and quantitative PCR (qPCR) revealing that F. nucleatum 
outnumbered Desulfobulbus sp. HOT41 by five to ten-fold in stationary phase (Figure 





Figure 2.1. Desulfobulbus sp. strain HOT041 (D. oralis) in coculture with Fusobacterium 
nucleatum and in pure culture. a. FISH using fluorescent oligonucleotide probes specific 
for Deltaproteobacteria (green) and universal Bacteria (red). b. Growth of Desulfobulbus 
sp. strain HOT041 and F. nucleatum in coculture monitored by species-specific qPCR 
(with error bars based on three biological replicates). (c and d). Scanning electron 










HOT41 always exhibited a lag phase but growth continued for days after F. nucleatum 
reached stationary phase. As initial experiments to isolate Desulfobulbus sp. HOT41 in 
pure culture by serial dilutions were unsuccessful, we hypothesized that the organism 
required metabolites produced by F. nucleatum in the co-culture and, because 
microscopic analysis did not reveal a stable physical interaction between the two 
organisms, that Desulfobulbus sp. HOT41 could acquire them directly from the co-culture 
medium. Such dependence on metabolic co-factors produced by other community 
members, including Fusobacterium, has been described for other oral bacteria as well 
(39, 41, 117). We therefore supplemented fresh culture medium with filter-sterilized 
medium from stationary-phase co-cultures (cell-free spent medium, CFS) and, by 
applying three successive rounds of dilution to extinction, we obtained pure cultures of 
Desulfobulbus sp. HOT41. Purity was determined microscopically by FISH and by deep 
rRNA amplicon and genome sequencing. The isolate was named Desulfobulbus oralis, 
its SSU rRNA being 99.6% identical to Desulfobulbus sp. HOT41 clone R004 (118). 
Physiological characterization of D. oralis. D. oralis is Gram-negative, non-
motile and non-sporulating, with rod-shaped cells 1-2 μm in length and 0.3 μm in 
diameter. Cells usually occur singly or in pairs although sometimes form longer chains. 
In scanning electron micrographs we observed the presence of outer membrane vesicles 
(25-50 nm in diameter) on some cells (Figure 2.1c,d). Such vesicles, common in Gram-
negative organisms including known oral pathobionts, have been shown to play important 
roles in interspecies interaction and to contain factors that trigger an inflammatory 
response (119, 120). 
For routine cultivation, we grew D. oralis anaerobically at 37°C in a minimal defined 
liquid medium with lactate as the sole carbon and electron source and sulfate as the 
electron acceptor, supplemented with 5% (v/v) F. nucleatum CFS. No growth occurred in 
the presence of trace levels of oxygen or in the absence of F. nucleatum CFS. We found 
that the soluble, growth-promoting component(s) of CFS could not be inactivated by 
heating or protease treatment and could not be substituted by defined supplements such 
as vitamins, amino acids, volatile fatty acids, siderophores or complex nutrients (yeast 
extract, peptone, brain-heart infusion), individually or in combinations. Therefore, the 
nature of the critical component(s) provided to D. oralis by F. nucleatum remain unknown 
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but such requirement has been documented for other human oral bacteria as well, 
including the Chloroflexi sp. HOT-439 (41) and Fretibacterium fastidiosum (39). Within 
the oral cavity, this type of interspecies dependence has become evident and is likely the 
main reason for recalcitrance to cultivation of many yet-uncultured species that, likewise, 
have lost the ability to synthesize a number of compounds and therefore must rely on 
other members of the microbiota (108, 121). CFS from a type strain of F. nucleatum 
(ATCC 23726) also supported the growth of D. oralis, indicating its physiological 
dependence is not restricted to the strain it co-enriched with, although we have not 
extended that analysis to additional strains or species.   
D. oralis is quite limited in the types of electron donors and acceptors it can utilize 
as an energy source for respiratory growth. Lactate and pyruvate are the only electron 
donors capable of being respired, while only sulfate or thiosulfate served as electron 
acceptors, out of all combinations tested (Table A2.1) (all additional material appears in 
the Chapter Appendix). Lactate was utilized with stoichiometric (1:1) production of acetate 
as the metabolic byproduct (Figure 2.2a) and the release of sulfide. Respiratory growth 
on pyruvate was very weak. We also tested D. oralis for its ability to ferment organic 
substrates in the absence of an electron acceptor (sulfate respiration). Growth was 
supported by pyruvate and weakly by amino acids but not by lactate, glucose, mucin, or 
peptone. Pyruvate was fermented to acetate and propionate in a 2:1 ratio (Figure 2.2b). 
In the subgingival space, sulfate could originate both from the blood and serum, where 
its concentration is relatively low (0.15mM) (122), but also a result of the connective tissue 
and bone breakdown during periodontal disease progression (122, 123). Lactate and 
pyruvate are released by other members of the oral microbiota and are important nutrient 
sources within the microbial oral biofilm (e.g. (124)). Therefore, we expect that D. oralis 
grows in vivo both by lactate-sulfate respiration and by pyruvate fermentation, depending 
on the local microenvironment and disease state.  D. oralis expands therefore the list of 
confirmed sulfate reducers in the oral cavity that includes species of Desulfovibrio and 
Desulfomicrobium. Sulfate reducers have long been associated with periodontal disease 
and their abundance correlated with disease severity (125). The availability of nutrients 
and especially sulfate may be limiting factors in their proliferation, as these organisms are 





Figure 2.2. Growth of D. oralis by respiration and fermentation. a. Time course cultivation 
using sulfate and lactate as the electron donor-acceptor pair, with the release of acetate. 
b. Substrate utilization and metabolic by-products of pyruvate fermentation. The error 











Comparative physiology and emergence of host association within the 
Desulfobulbus genus. Host-association leads to a reduced metabolic versatility, as the 
chemical and biological environment is relatively stable. This was evident as we 
compared the ability of several Desulfobulbus species to utilize various growth substrates 
(Table A2.1). All of the free-living isolates are able to utilize a wider range of substrates 
as electron donors and acceptors and for fermentation than D. oralis. Notably, propionate 
respiration and lactate fermentation, common traits among all free-living Desulfobulbus, 
have been lost in D. oralis. Within the Desulfobulbus genus, host association is not 
restricted to humans, as closely related uncultured species have been detected in the 
oral microbiota of domesticated dogs (126) and cats (127). We performed a phylogenetic 
analysis using full length SSU rRNA gene sequences, which suggested that mammalian 
host association was likely the result of an ancestral oral colonization by a free living 
Desulfobulbus, most closely related to D. oligotrophicus (Figure 2.3). Additional 
sequences from other mammalian lineages as well as cultivation of other host-associated 
Desulfobulbus would be required to better understand the co-evolution of these bacteria 
with their hosts.  
Genome sequencing, annotation, and metabolic reconstruction. We obtained 
the complete genome sequence of D. oralis using long read sequencing (PacBio). The 
assembly resulted in a single contig (>600 fold coverage), which was circularized as a 
single chromosome of 2,774,417 base pairs, with a G+C content of 60%. We further used 
mapping of Illumina short reads to correct any potential sequence and assembly errors. 
Gene prediction and annotation was performed in both Genbank and IMG and was 
supplemented with annotations based on Pfam, KEGG  and eggNOG (128) (Dataset  
S2.1). The D. oralis genome encodes 2,395 proteins (GenBank), 51 tRNAs, and has 2 
rRNA operons. A slightly larger number of proteins were predicted with IMG (2442) and 
we identified the differences as small hypothetical proteins and mobile genetic elements 
(transposases).  
When compared to genomes of environmental Desulfobulbus species (Table 
A2.1), the genome of D. oralis is 30-50% smaller. There is also limited gene synteny 
based on comparison with the only closed genome of an environmental Desulfobulbus 






Figure 2.3. Maximum likelihood phylogeny of Desulfobulbus and related 
Deltaproteobacteria. The tree is based on full-length SSU rRNA gene sequences. Node 
















Figure 2.4. Genomic comparison of D. oralis and D. propionicus. Matching orthologs are 
connected by internal arc lines, the color scale indicating the degree of pairwise sequence 
identity at the protein level. External tick lines indicate genes in each genome that contain 
protein domains enriched (blue) or depleted (red) in D. oralis (based on data in Data Set 
S2). The outer histograms (light blue) indicate the relative abundance of each detected 
protein in D. oralis cells (bottom) or culture medium (top). Secreted proteins significantly 





associated with genomic fragmentation. For metabolic reconstruction, we combined 
assignments from IMG, KEGG’s BlastKOALA, and MetaCyc, with similarity searches, 
domain architecture analyses, sequence alignments, and phylogenetic reconstruction for 
comparisons of enzymes and pathways with other sulfate reducers and oral bacteria. 
As physiological characterization of D. oralis revealed streamlining and loss of 
some of the free-living Desulfobulbus respiratory and fermentative capabilities, the first 
objective in metabolic reconstruction was to predict the bioenergetics and carbon flow 
associated with respiratory versus fermentative growth in the oral environment. The 
dissimilatory sulfate reduction pathway (129), common to all Desulfobulbus species, 
could be reconstructed based on the D. oralis genome and is proposed to follow 
transformations represented schematically in Figure 2.5. Sulfate enters the cell via a SulP  
permease and is activated by adenylation via a sulfate adenylyl transferase (Sat). The 
resulting pyrophosphate is hydrolyzed by a manganese-dependent inorganic 
pyrophosphatase (ppaC), which drives the otherwise endergonic activation step. The 
adenosine 5’-phosphosulfate is converted to sulfite by APS reductase (Apr), a 
heterodimeric iron–sulphur flavoprotein complex, which receives electrons from a 
membrane-bound oxidoreductase complex (QmoABC) that interacts with the quinone 
pool as part of the energy conservation cycle (130). Sulfite is further reduced to sulfide 
by the dissimilatory sulfite reductase (Dsr), a large enzyme complex that includes 
cytoplasmic, membrane anchored and periplasmic subunits including cytochromes b and 
c, quinone interacting domains, and iron sulfur centers that mediate electron transfer and 
proton translocation (Figure 2.5).  Another energy-conserving membrane complex 
present in D. oralis shares homology with the membrane-bound NADH dehydrogenase 
complex Nuo and is encoded by an eleven-gene cluster. However, the NuoEFG subunits, 
responsible for oxidizing NADH, are missing, so the complex may oxidize a different 
electron donor, such as reduced ferredoxin, similar to other sulfate reducers (131). The 
Nuo complex is complete in D. propionicus.  
A cytoplasmic Hdr–Flx complex that can perform an alternative mode of energy 
conservation, flavin-based electron bifurcation (FBEB)(132) is present in D. oralis but 
absent in free living Desulfobulbus. The complex appears to have originated from a 





Figure 2.5. Metabolic reconstruction of D. oralis, with emphasis on membrane processes, 
energy conservation, and pathogenicity potential. Selected genes encoding enzymes, 
complexes, and other proteins proposed to function in such cellular processes are 
indicated by numbers in red, corresponding to GenBank genes in Data Set S1. The 
putative EtfAB-Ldh complex is depicted in gray.   
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human oral D. fairfieldensis. The FlxABC complex has FAD, NAD(P)-binding sites, and 
an iron-sulfur center, representing a distinct type of NAD(P)H dehydrogenase, which was 
proposed to oxidize NAD(P)H using both ferredoxin and a high redox disulfide center 
(DsrC) as electron acceptors (133). The reverse reaction, NAD+ recycling to NADH, can 
be coupled in environmental Desulfovibrio with aldehyde conversion to ethanol during 
pyruvate fermentation, using electrons coming from reduced ferredoxin through HdrABC 
(133). While we did not detect alcohol production by D. oralis, a related aldehyde 
detoxification process could occur through an NADPH-dependent alcohol dehydrogenase 
(CAY53_10125), most closely related to genes from human and animal-associated 
Actinobacteria. The interconversion between reduced and oxidized forms of NAD(H) and 
NADP(H) is performed by NfnAB, also an electron-bifurcating, ferredoxin-dependent 
flavoprotein. Another complex with a role in detoxification is the cytochrome c-containing 
nitrite reductase, NrfAH. This membrane complex, present in pathogenic bacteria, 
detoxifies nitric oxide produced by host cells as a defense mechanism against bacterial 
invasion (134). 
Oxidation of lactate to pyruvate during sulfate respiration is catalyzed by a 
peripheral membrane associated multisubunit lactate dehydrogenase (LutABC) that uses 
the menaquinone pool as the electron acceptor. The complex is encoded in the same 
operon with a lactate permease (LutP) and appears to have been acquired from host 
associated Desulfovibrio, lacking close homologues in environmental Desulfobulbus. 
Lactate is an important shared substrate among many oral bacteria and the acquisition 
of the Lut system by D. oralis likely reflects an important adaptation to this environment 
following colonization. Pyruvate is further decarboxylated to acetyl-CoA by a 
pyruvate:ferredoxin oxidoreductase, generating reduced ferredoxin. D. oralis has lost 
both phosphate acetyl transferase and acetate kinase and we hypothesize that acetate 
release occurs via CoA transfer by a succinate:acetate-CoA transferase, that was likely 
acquired from a host-associated Campylobacter (Figure A2.1), followed by trans-
phosphorylation by succinate thiokinase and nucleoside diphosphate kinase (Figure 2.5). 
This pathway is consistent with the observed 1:1 stoichiometry of lactate conversion to 
acetate (Figure 2.2a). It would result in the production of one ATP per lactate via 
substrate level phosphorylation and an additional amount of ATP via sulfate respiration 
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that depends on the number of protons translocated across the cytoplasmic membrane 
and the coupling number of the F0F1 ATPase.  
 For free-living Desulfobulbus, lactate can also be fermented. An electron-
bifurcating, cytoplasmic lactate dehydrogenase-flavoprotein complex (Ldh-Etf) oxidizes 
lactate to pyruvate by coupling the endergonic NAD+-dependent oxidation of lactate to 
the exergonic electron transfer from reduced ferredoxin to NAD+ resulting in the oxidation 
of one ferredoxin and the production of 2 NADH (135). For every three pyruvate produced 
from lactate, one is converted to acetate, generating reduced ferredoxin and an ATP by 
substrate level phosphorylation, while two more pyruvate molecules are reduced to 
propionate. This would result in an expected product ratio of 2:1 propionate to acetate 
(136).  Even though we did not detect fermentative growth on lactate, D. oralis has a 
potential Ldh-Etf complex encoded in its genome. It is therefore possible that it may 
ferment lactate in vivo, and that the inability to do so under pure culture conditions is due 
to insufficient protein expression. In fact, based on whole cell proteomic analysis (detailed 
below) we found that the Ldh complex subunit was present at extremely low levels 
(~0.001% of the proteome), two orders of magnitude below that of the Etf subunits. In the 
absence of lactate fermentation, D. oralis can nevertheless ferment pyruvate through the 
propanoate cycle. In this case, for every three pyruvate molecules, two can be converted 
to two acetate molecules with the generation of two ATP and two reduced ferredoxins, 
while one additional pyruvate serves as an electron acceptor and is reduced to 
propionate. This results in the expected ratio of 1:2 propionate to acetate during pyruvate 
fermentation, consistent with our observed results (Figure 2.2b).  
 D. oralis has incomplete pathways for the biosynthesis of several amino acids 
(serine, threonine, cysteine, tyrosine, and phenylalanine) as well as for biotin, 
molybdenum cofactor, and cobalamin. Amino acid and vitamin auxotrophies are common 
among bacteria that live within complex communities such as the oral microbiota. 
However, D. oralis has additional, yet unidentified dependencies; simple supplementation 
with amino acids, peptides and/or vitamins did not relieve the requirement for the 
Fusobacterium culture filtrate. Nucleotide biosynthesis and conversion appears fully 
functional and D. oralis can also synthesize a variety of fatty acids and sugars for 
membrane, peptidoglycan, and lipid A assembly. Future elucidation of this nutritional 
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requirement may enable more rapid isolation of other fastidious microorganisms from 
human microbiomes. 
Genomic fingerprints for adaptation to a host-associated environment and 
potential pathogenicity. Desulfobulbus oralis has a reduced genome which displays 
limited conserved gene synteny when compared to its closest sequenced free-living 
relative (Figure 2.4), as well as evidence for both gene loss and gene gain. Aside from 
becoming dependent on exogenous amino acids and vitamins, gene loss has affected 
hydrogenases, ferredoxin oxidoreductases, cytochromes, the dissimilatory nitrate 
reductase, and pyruvate kinase. This restricts D. oralis from utilizing a wider range of 
electron donors and acceptors and fermentation substrates that are not present at high 
concentrations in the oral environment (nitrate, short chain fatty acids, and alcohols).  As 
very few organisms from the oral microbiota are capable of sulfate respiration, the 
restricted energy metabolism in D. oralis may reflect its adaptation to a metabolic niche 
in which there are few competitor species, with no selection to maintain metabolic 
versatility typical of free living Desulfobulbus species.   
Following host colonization, cohabitation with bacteria not present in open 
environments presents the opportunity for horizontal gene transfer and acquisition of 
physiological traits that are absent in free-living species. Horizontal gene transfer is an 
important factor influencing the human oral microbiota and its individual species’ positive 
and negative interactions with the host (137, 138). Based on sequence similarity and 
phylogenetic analyses, we found evidence for multiple horizontal gene transfer events.  
Sixty percent of the D. oralis genes have their closest homologs in the genomes of free-
living Desulfobulbus and potentially can be regarded as inherited from the ancestral 
lineage that colonized the mammalian oral environment (Dataset S2.1).  Approximately 
200 predicted protein-encoding genes (~8% of the genome) have no distinguishable 
homologues, most of them being quite short and without recognizable protein domains. 
Out of the remaining genes, >250 (10%) are most closely related to homologues from 
other Deltaproteobacteria and have the oral Desulfovibrio fairfieldensis and 
Desulfomicrobium orale as the top hits, suggesting they might have been acquired from 
such physiologically-related lineages. Among those genes are clusters encoding for a 
variety of transporters and energy conservation complexes (lactate dehydrogenase, 
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glycerol-3-phosphate dehydrogenase, heterodisulfide reductase). Other potential 
horizontally acquired genes include transporters, drug and antibiotic efflux pumps, 
hydrolases, glycosyl transferases involved in cell membrane biosynthesis, CRISPR 
system proteins, and other enzymes and regulators from a wide range of oral bacteria, 
including Actinomyces, Streptococcus, Porphyromonas, Tanerella, Prevotella, Neisseria, 
and Campylobacter (Figure A2.1). As far as gene absence, it was notable to find that the 
hgcA and hgcB genes, present in all environmental Desulfobulbus identified so far (139), 
have been lost in D. oralis. Those genes encode a corrinoid iron-sulfur protein (HgcA) 
and a ferredoxin (HgcB) that are responsible for the microbial synthesis of methyl 
mercury, a potent neurotoxin (140). While the biological role of HgcA-B is still unknown, 
the finding that D. oralis has lost that biochemical potential represents a highly significant 
positive outcome of adaptation to the oral microbiota, especially considering mercury 
amalgam tooth fillings continue to be used and are present in many individuals.  
To get a more quantitative estimate on gene family loss and gain in the D. oralis 
genome relative to its free-living relatives, we performed functional abundance profile 
analyses in IMG (Dataset S2.2). At the protein domain (Pfam) level, several categories 
of transposases and other mobile elements (integrases and endonucleases) are highly 
enriched in D. oralis as compared to other Desulfobulbus. Phylogenetically, many of those 
genes appear to be related to Desulfomicrobium and may reflect multiple genetic 
exchanges between these two related sulfate reducers in the oral microbiota. At the gene 
family level (COG), aside from mobile elements, COG families involved in membrane lipid 
biosynthesis and transporters are enriched. Considering that D. oralis relies on 
exogenous amino acids, it is not unexpected to see that amino acid and peptide ABC 
transporters are at higher abundance than in other Desulfobulbus, and some of the genes 
were likely acquired from other oral bacteria by HGT. Four genes (9825, 9840-9855) that 
encode members of an ankyrin repeat protein family that may be involved in the 
interaction with human cells (141), absent in free-living Desulfobulbus, were also 
apparently acquired from oral Synergistetes (Figure A2.1).  
With respect to gene loss, the most pronounced difference between D. oralis and 
its free-living relatives were observed in the category of signal transduction and gene 
regulation (Dataset S2.2). Indeed, this functional category shows the steepest 
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dependence on the total number of genes in bacteria and archaea (142); however, D. 
oralis presents significant deviation from the general trend. While the number of genes in 
D. oralis is only 30% smaller than that in a free-living D. propionicus, the number of signal 
transduction genes in D. oralis is 4.5 times smaller: 72 genes (Dataset S2.3) versus 320 
genes in D. propionicus (data from the MiST database (143)). Such deviations were 
proposed to reflect particular biological phenomena as well as environmental conditions 
in a microbial habitat (144). Thus, we explain a disproportional loss of signal transduction 
capabilities in D. oralis as a direct result of adaptation to a much more stable niche, where 
constant temperature, pH, and set of nutrients eliminate the need to monitor and respond 
to various environmental factors. The absence of swimming motility in D. oralis is yet 
another conspicuous example of adaptation to a new environment via gene loss. While 
free-living representatives of Desulfobulbus contain a full complement of flagellar genes 
and chemotaxis machinery (more than 50 genes), D. oralis lost all of these genes. 
However, it retained type IVa pili (TFP) that are essential for active translocation across 
solid surfaces, including PilT, a marker gene for TFP-based motility, as well as two 
regulatory chemosensory systems that belong to TFP class (Dataset S2.4). Thus, despite 
the loss of flagella and chemotaxis, D. oralis is capable of actively navigating toward 
beneficial microenvironments within the oral cavity.  
As the relatively streamlined metabolism of D. oralis does not suggest it could 
provide the human cells with vitamins or other beneficial factors, we searched for potential 
genes that could mediate evading the host defense system and a potential role in 
pathogenesis.  One such candidate gene family encodes eight proteins containing the 
Sel1 domain, characteristic of solenoid proteins involved in a variety of signal transduction 
processes (145). Three of the D. oralis Sel1 domain proteins are related to proteins that 
are involved in the bacterial interaction with human cells including evasion of lysosomal 
host defense mechanisms, such as the Legionella LpnE and LidL (146) and yet 
uncharacterized proteins from opportunistic pathogens like Neisseria, Haemophilus and 
Kingella (147-150) (Figure A2.1). Another relative of those proteins are EsiB (Escherichia 
coli secretory immunoglobulin A-binding protein), a pathogenic E. coli marker (151) 
confirmed to have host immune modulatory activity by interacting with secretory IgA, thus 
leading to inhibition of neutrophil activation and evasion of host defense mechanisms 
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(152, 153). This ultimately allows E. coli to avoid clearance by the host’s immune system 
and permits further infection. A similar role could be employed by D. oralis to avoid 
negative effects of host immune responses in periodontal disease progression allowing 
for its proliferation and increase in abundance. D. oralis also encodes genes for 
leukotoxin/hemolysin production and export through type I secretion systems. 
Leukotoxins belong to the RTX toxin family, broadly distributed among Gram-negative 
bacteria and with diverse biological functions. Leukotoxin produced by the periodontal 
pathobiont Aggregatibacter actinomycetemcomitans are lethal to human monocytes and 
human T lymphocytes in vitro (154, 155) and are a main virulence factor within deep 
periodontal pockets in aggressive periodontitis (156-158). Genes encoding other RTX 
family homologues include adenylate cyclase/hemolysin, which is the major virulence 
factor of Bordetella (159-161), as well as an outer membrane translocation complex 
involved in RTX protein processing and export (157). Based on these findings, we 
propose that leukotoxin/hemolysin systems of D. oralis, acquired as three distinct operons 
(Dataset S2.5), could play roles in the putative pathogenicity of D. oralis by contributing 
to host immune evasion, manipulation, and neutralization of defense mechanisms.  
Proteomic analysis of D. oralis and its pathogenicity potential. While genome 
analysis revealed both native and acquired physiological potential, including the 
possibility that D. oralis may play an active role in the etiology of periodontal disease, 
simple gene presence is not sufficient evidence to assume that every potential gene 
product is actually expressed. We therefore applied a proteomic approach to determine 
the relative amounts of every expressed protein within the cell, and whether specific 
proteins are released into the extracellular space. Because the main focus was on 
proteins that may contribute to pathogenesis, some of which were predicted to be 
membrane- anchored while others secreted into the extracellular space, we collected both 
cells and filtered culture supernatant. Three separate culture replicates were performed 
and the samples for analyses were collected in late log phase.  
 One of the primary metabolic byproducts of D. oralis sulfate respiration, hydrogen 
sulfide, is well-known to trigger an inflammatory response at the leukocyte-endothelium 
interface, acting as a primary signaling molecule and synergizing with the pro-
inflammatory action of virulence factors (162, 163). As we wanted to test the synthesis 
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and potential pro-inflammatory action of potential virulence factors encoded by D. oralis, 
we grew the cells fermentatively, in the absence of sulfate. The whole-cell proteome and 
the soluble proteins released into the medium were fragmented and analyzed by bottom-
up, two-dimensional liquid chromatography tandem mass spectrometry (2D-LC-MS/MS). 
A total of 1628 proteins were detected, representing 70% of the predicted proteome 
(Datasets S2.1 and S2.6), which is similar to coverage that has been previously obtained 
on other organisms with reduced genomes (164, 165). Considering that proteins 
containing multiple transmembrane domains are difficult to detect in tryptic digests (here 
we detected only 40% of the proteins predicted to contain more than 1 transmembrane 
domain) we conclude that a very large fraction of the D. oralis genetic potential (>80%) 
was expressed under the tested condition. We also detected most of the putative 
virulence factors (hemolysins, leukotoxin, Sel1 proteins) and the proteins involved in their 
processing and export. In terms of dynamic range, we detected proteins spanning five 
orders of magnitude in relative abundance, from 2% of the cell total cellular proteome 
(sulfite reductase) to 2e-5% (a type IV transporter subunit). The most abundant proteins 
were determined to be enzymes involved in energy conversion and central metabolism, 
protein translation, chaperones, regulators, and several transporters. While the high-level 
of proteins involved in respiratory growth may appear surprising, it has been shown in 
other sulfate reducers grown under fermentative conditions that the sulfate reduction 
pathway is constitutively expressed (166). This indicates that the sulfate reduction 
capacity of D. oralis is actively maintained and, when periodontal sulfate levels are 
adequate, it may be the primary energy source.  
 To identify if any of the putatively expressed virulence factors were secreted, we 
compared the proteome of whole cells against their secretome. We identified 12 proteins 
that were significantly enriched in the culture medium relative to their abundance in whole 
cells (Figures 2.4 and 2.6, Dataset S2.6). With the exception of two, a DNA binding factor 
and an unknown protein, all others were predicted hemolysin family proteins and were 
enriched between 40-100 fold in the culture medium, suggesting that the cells actively 
secreted them. In vivo, such secreted hemolysins could diffuse through the epithelial 





Figure 2.6. Proteomics and cytokine stimulation implicating D. oralis in proinflammatory 
responses. a. D. oralis proteins that are secreted from the cell (indicated in red) based on 
enrichment analysis. Only proteins that had at least a 4-fold enrichment and P<0.01 
(based on three biological replicates) were considered. The table on the right identifies 
those secreted proteins and compares them to their closest homologues in the human 
oral microbiota or the free-living Desulfobulbus. b. Cytokine stimulation in oral epithelial 
keratinocytes by D. oralis cells. Keratinocytes were incubated with D. oralis cells or with 
the medium control for 48h, and cytokine stimulation was measured using a multiplex 
bead assay. Each bar represents the mean +/- standard deviation of the mean from 
triplicate measurements. Asterisks indicate results significantly different from the 
keratinocyte medium-only control: *, P<0.05; **, P<0.01.   
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D. oralis cytokine stimulation in oral epithelial keratinocytes. During the initial 
stages of periodontal disease there is an acute inflammatory response to some of the oral 
microbiota resulting in the recruitment of polymorphonuclear leukocytes stimulated by 
host chemokines and/or cytokines, such as IL-8 (167). As inflammation progresses from 
acute to chronic, an increase in the production of pro-inflammatory mediators such as IL-
1β, IL-6, IL-8, and TNF-α by various host cells, including oral epithelial keratinocytes, 
results in the recruitment of additional immune cells such as macrophages, T-cells, and 
B-cells (167). Various recognized periodontal pathobionts trigger distinct types of 
inflammatory responses (168-170) and some (e.g. Porphyromonas gingivalis) can 
modulate that by interfering with chemokine production (171).  
Based on the finding that D. oralis secretes and has surface associated proteins 
(e.g., leukotoxin, hemolysins, esiB-Sel1) that have been shown in other oral bacteria to 
be linked to an inflammatory response in periodontitis, we analyzed its ability to induce 
pro-inflammatory cytokine production in vitro. We used a human immortalized oral 
keratinocyte cell line (OKF6/TERT2), which has been previously used as a model to study 
the interaction of oral bacteria with human epithelial cells (169, 172). Cells and filtered 
medium from the same D. oralis cultures used for proteomic analyses were applied to 
epithelial cells in culture and the production of 13 human inflammatory 
cytokines/chemokines was measured after 48 hours using bead-based immunoassays. 
We detected a significant stimulation of IL-1β release by the keratinocytes exposed to D. 
oralis culture filtrate while IL-1β, IFN-α, IFN-γ, MCP-1, IL-6, IL-8, and IL-18 were 
stimulated when keratinocytes were exposed to D. oralis cells (Figure 2.6 and Figures 
A2.2 and A2.3). The difference in pro-inflammatory responses between culture medium 
and whole cells are due to protein concentration differences, as the enriched proteins in 
the medium (secreted leukotoxins/hemolysins) and the bacterial cell surface agonists 
(e.g. Sel1 proteins, surface pili, LPS) may activate different pathways. The strongest 
stimulation was observed for IL-8 (p<0.01). IL-8 is one of the most important chemokines 
associated with periodontitis, being elevated at the disease site and attracting neutrophil 
polymorphs that further increase pro-inflammatory mediators (167). The observed 
release of the other cytokines/chemokines is expected to stimulate B- and T-cell 
differentiation as well as attracting macrophages and natural killer cells to the site of 
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infection. The absence of stimulation of IL-10 and IL-12, both anti-inflammatory cytokines, 
does not support a potential beneficial role of D. oralis. On the other hand, the complex 
response triggered by D. oralis in epithelial cells indicates that this bacterium is not merely 
a colonizer in the low oxygen deep periodontal pockets but actively participates in 
inflammation. During periodontal disease progression the gingival extracellular matrix 
breaks down and glycosaminoglycans (GAGs) are released (123, 173). D. oralis encodes 
several sulfatases that could liberate inorganic sulfate from GAGs potentially playing an 
active role in matrix destruction (174). In addition, the hydrogen sulfide produced by D. 
oralis during sulfate respiration can lead to apoptosis in keratinocytes (163, 175) and 
further elicits a pro-inflammatory response in oral cells (176, 177). These features 
illustrate the capacity of D. oralis to create a dysbiotic oral environment and actively 
contribute to the pathogenesis of periodontal disease in a novel and compounded way, 
not described for other oral pathogens so far. These results emphasize that cultivation of 
novel bacteria, only associated with disease based on sequence data, is important to 
begin to fully understand their role in the oral cavity. 
Expression of D. oralis pathogenicity genes in periodontitis. A recent clinical 
metatranscriptomic study identified Deltaproteobacteria as one of the bacterial lineages 
that increase in prevalence and transcriptional activity in periodontitis (178). We therefore 
aimed at determining the functional profile of D. oralis and specifically the relative 
abundance of its pathogenicity gene transcripts, based on this RNAseq data generated 
from oral clinical samples. We determined that in the datasets from three individuals with 
periodontitis, the sequences that mapped to D. oralis protein encoding genes (~3000- 
25,000 reads) represent 0.1-0.5% of the total number of microbial reads. Even though the 
overall coverage of the D. oralis transcriptome by the RNAseq datasets was shallow (<two 
fold), across the three datasets >80% of the predicted gene transcripts were detected 
(Dataset S2.1), with ~65% of the genes represented by at least two reads. This correlates 
with the overall number of proteins we detected in D. oralis grown in pure laboratory 
cultures and supports the hypothesis that most genes in this bacterium are expressed 
both in vitro and in the natural subgingival environment. While the coverage level was too 
low to enable a robust global comparison of the transcriptional versus proteome profile, 
we analyzed the relative levels of mRNAs encoding putative pro-inflammatory response-
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inducing proteins. Several of the hemolysin-type genes were amongst the top 50 most 
abundant transcripts (0.2-1% of the mapped reads), with four of them being part of a 
highly expressed operon (CAY53_915-940) (Dataset S2.5). This indicates that such 
factors, which have been linked to inflammatory response in other oral bacteria, are being 
actively produced by D. oralis in the subgingival space and likely play a role in the 
development and progression of periodontal disease.   
Description of Desulfobulbus oralis sp. nov. Desulfobulbus oralis sp. nov. 
(o.ra’lis. N.L. masc. adj. oralis of the mouth). Cells are non-motile, non-spore-forming 
Gram-negative rods 1-2 μm in length occurring singly, in pairs, and sometimes chains. 
Growth occurred at 37°C with optimum pH 7-7.1 under strictly anaerobic conditions, with 
cysteine as a reducing agent. D. oralis incompletely oxidizes lactate and pyruvate to 
acetate, using sulfate or thiosulfate as electron acceptors and releasing sulfide. The 
organism does not utilize citrate, propionate, acetate, hydrogen, formate, succinate, 
glucose, fructose, ethanol, propanol, fumarate or malate as electron donors or sulfite and 
nitrate as acceptors. In the absence of electron acceptors, pyruvate and amino acids are 
fermented while lactate, peptone, mucin, and dextrose are not. Growth requires the 
addition of 5% Fusobacterium nucleatum cell-free spent medium (CFS). 
D. oralis type strain ORNL was isolated from a human subgingival sample from a 
patient with periodontitis at Ohio State University College of Dentistry, Columbus, Ohio. 
The genome is represented by a circular chromosome of 2.77 Mbp and with G+C content 
of 59.76 mol%. 
 
Materials and Methods   
Clinical sample collection. Subgingival biofilm and crevicular fluid was obtained 
from a patient with periodontitis at the Ohio State University College of Dentistry. Informed 
consent was obtained, under a protocol approved by the Ohio State University IRB 
(2007H0064). Following removal of supergingival plaque with gauze, sterile endodontic 
paper points were inserted into the gingival sulcus and left for one minute. Afterwards 
they were placed into Liquid Dental Transport Medium (Anaerobe Systems, Morgan Hill, 
CA) and used for inoculation into primary enrichment medium. 
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Microbial cultivation. Primary oral enrichments were passaged (2% v/v) in an 
ATCC 1249 modified Baar’s medium containing (per liter): 2g MgSO4.7H2O, 1g 
(NH4)2SO4, 0.5g K2HPO4, 1g CaCl2.2H2O, 5g sodium citrate, 1.17g sodium propionate, 
1.17g sodium acetate, 1.5mL L(+)-lactic acid (85% w/v, Sigma), 1g yeast extract, and 0.5 
mg resazurin. The medium was degassed with N2/CO2 (80/20, v/v), sterilized for 15 
minutes at 121°C followed by addition of sterile degassed cysteine (1mM final 
concentration) and 10mL Fe(NH4)2(SO4)2 5% (w/v) and pH adjustment to 7.2 with 8M 
NaOH. Cultures were maintained in 15 mL glass tubes fitted with butyl rubber stoppers, 
under N2/CO2 (80/20, v/v) at 37°C for 1-2 weeks. Cell growth resulted in the release of 
hydrogen sulfide, which formed a black iron sulfide precipitate and was also detected 
using lead acetate indicator paper. Stocks were preserved by freezing at -80°C, after 
adding DMSO to 10% (v/v). Cell-free spent medium supernatant (CFS) was prepared by 
filtering cultures through two 0.22μm NalgeneTM Rapid-FlowTM sterile filters and 
degassing with N2 (100%). Pure cultures were obtained by three successive dilutions to 
extinction transfers in liquid medium. For culture enrichments of D. oralis, the medium 
was supplemented with 25% (v/v) co-culture CFS. Pure cultures of D. oralis were grown 
in a modified Lactate-Baar basal medium containing (L-1 distilled water): 2g MgSO4.7H2O, 
1g (NH4)2SO4, 10mM MOPS, 10mM HEPES, 10mM sodium lactate, 0.1% yeast extract, 
2.5mM cysteine, and 0.5 mg resazurin 0.5%. The pH of the media was adjusted to 7-7.1 
with 8M NaOH, degassed with N2 (100%) and autoclaved for 30 minutes at 121°C. After 
cooling, sterile K2HPO4 (0.5M, pH 7) was added to 3mM final and CFS of F. nucleatum 
grown in brain-heart-infusion broth (BHI) supplemented with 0.2% glucose was added to 
5% (v/v). In subsequent experiments we determined that the addition of yeast extract was 
not necessary for growth. 
Cellular and molecular analyses. Fluorescence in situ hybridization (FISH) with 
the oligonucleotide probes EUB338 (Bacteria) and Delta495a  (Deltaproteobacteria) was 
performed as previously described (33). For DNA isolation we used proteinase K 
digestion followed by phenol-chloroform extraction (164). PCR-amplification of the 16S 
rRNA gene was carried out using the universal primer set 27F (5’-
AGAGTTTGATYMTGGCTCAG-3’) and 1492R (5’-TACGGYTACCTTGTTACGACTT-3’) 
or a specific D. oralis set DsbF (5’-AGTTAGCCGGTGCTTCCT-3’) and 1492R. 
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Amplification with Lucigen 98HotStart Supermix used the following thermal profile: 94°C 
for 3 minutes, followed by 32 cycles of 94°C for 20 seconds, 60°C for 30 seconds, 72°C 
for 90 seconds, and a final extension of 72°C for 5 minutes. Following purification, the 
PCR products were sequenced directly using Sanger chemistry (ABI 3730) or were first 
cloned into pCRTM2.1-TOPO (Invitrogen, Carlsbad CA, USA). Sequence data was 
analyzed using Geneious v.10 (179) and confirmed the in silico-inferred primer specificity. 
To quantitatively determine the co-culture composition, we developed a qPCR assay 
using 16S rRNA gene primers specific for F. nucleatum (5’-
CAGCGTTTGACATCTTAGGA-3’ and 5’-ATCGTAGGCAGTATCGCAT-3’) and for D. 
oralis (5’-GGTGGTGCCTTCTTTGAA-3’ and 5’-TTCCTCCGGTTTGAC ACC-3’). 
Amplification was with BioRad iQ SYBR Green Supermix in a CFX96TM Real-Time C1000 
thermal cycler (Bio-Rad, Hercules, CA), using a plasmid-cloned 16S rDNA insert and the 
following thermal profile: 95°C for 3 minutes, followed by 40 cycles of 95°C for 20 
seconds, 66°C for 30 seconds. Sanger sequencing confirmed primer specificity for each 
species and primers pair.  
For scanning electron microscopy cells from 20 ml of culture were collected onto 
a 0.1μm PVDF syringe filter, washed with phosphate buffered saline (PBS, pH 7), fixed 
with 3% glutaraldehyde in PBS for 1 hour at room temperature, followed by three 10 
minutes wash steps with PBS. Fixed cells were resuspended in 2% osmium tetraoxide in 
PBS for 1 hour, collected by centrifugation at 10,000 x g for 5 minutes, and washed three 
times in water (10 minutes each). On the final wash, cells were deposited onto a 3X4mm 
silicon chip (Ted Palla, Inc, CA) for 15 minutes followed by dehydration in an ethanol 
series (50, 70, 95, 100%), 10 minutes each. The cells were dried in a Ladd critical-point 
dryer then gold-coated using an SPI sputter coater and examined on a Zeiss Auriga 
Focused Ion Beam Scanning Electron Microscope.  
Physiological characterization. Optimum pH was determined in Lactate-Baar 
medium containing 5% F. nucleatum CFS, and 15mM MES, MOPS, and/or HEPES, with 
the pH adjusted between 5 and 8 at 0.5 unit intervals (MES for pH 5-6, MES + MOPS for 
pH 6.5, MOPS for pH 7, MOPS + HEPES for pH 7.5, and HEPES for pH 8). Growth was 
monitored for one week at 37°C by daily measurements of optical density at 600nm. 
Utilization of electron donors was determined in Lactate-Baar medium containing 5% F. 
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nucleatum CFS and each substrate at 10mM. Substrates tested include citrate, 
propionate, acetate, lactate, formate, fumarate, succinate, malate, pyruvate (all as sodium 
salts), glucose, fructose, ethanol, and propanol. Hydrogen utilization was determined in 
the presence of sodium acetate and H2/CO2 (80/20, v/v).  Utilization of electron acceptors 
was determined with sodium lactate (10mM) in minimal sulfate-free medium (L-1 distilled 
water): 2g MgCl2, 1g NH4Cl, 1g yeast extract, 10mM MOPS, 10mM HEPES, 3 mM 
K2HPO4, 2.5mM cysteine, 0.5 mg resazurin and 5% F. nucleatum CFS and containing 
20mM sodium sulfate, sulfite, thiosulfate or nitrate. Fermentative capabilities were 
determined in the same basal medium used for the electron acceptor test, however 
lacking addition of electron donor-acceptor pairs. Substrates tested for fermentation 
include sodium lactate (20mM), sodium pyruvate (20mM), peptone (0.1%), mucin 
(0.25%), synthetic amino acids supplements (Y1501, Sigma)(0.2%), or dextrose (0.2%).  
F. nucleatum CFS susceptibility to inactivation was tested by treatment (2 hours at 
37°C) with proteinase K (0.2 mg/mL) or incubation at 80°C for 14 hours prior to 
supplementation into Lactate-Baar medium at 5% v/v. For testing potential replacement 
of CFS with defined amino acids, vitamins, and siderophores, yeast synthetic dropout 
media (amino acids) were added to 0.2% and ATCC vitamins to 1% in Lactate-Baar media 
prior to inoculation. Siderophore mixture contained a 1:1:1 mix of pyoverdines, 2,3-
dihydroxybenzoic acid, and ferrichrome and were added to a final concentration of 
1g/ml.  The cultures were monitored by optical density and microscopic examination for 
two weeks. Very weak growers were transferred to fresh media and monitored for growth 
up to 1 month. Growth was considered positive if an increase in OD600 occurred after 
three consecutive passages. All experiments were performed in triplicate. 
To determine metabolic byproducts of lactate respiration and pyruvate 
fermentation, soluble analytes were measured via high-performance liquid 
chromatography (HPLC) using a Waters Breeze 2 system (Waters Corp., Milford, MA, 
USA) equipped with a refractive index detector (model 2414) and an Aminex HPX-87H 
column (Bio-Rad Laboratories). Sulfuric acid (5mM) was used as the mobile phase at a 




Genomic sequencing and analysis. D. oralis genomic DNA isolated using the 
phenol-chloroform method described (164) was used to construct of a large insert (20kb) 
library for sequencing on a PacBio RS II system (Institute for Genome Sciences, 
University of Maryland School of Medicine). We generated 154,149 reads, with N50 
length of 20.2 kbp and median of 14 kbp, which were assembled into one polished contig 
2,796,768 bp in length, with 668 mean coverage, using PacBio SMRT Portal. We also 
sequenced in-house a small insert D. oralis genomic library on an Illumina MiSeq 
platform. Approximately 4 million reads (2x250 nt) were mapped on the PacBio contig 
using Geneious v.10. (179). Individual indel discrepancies were resolved based on both 
read coverage and inspection of their effect of disruption/truncation of predicted ORFs in 
that region. Contig end overlaps were identified which resulted in circularization of the 
initial contig into one chromosome of 2,774,417 bp. The finished genome was submitted 
to GenBank for gene prediction and annotation using NCBI PGAP (accession number 
CP021255) and to JGI IMG (IMG Genome ID 2711768589). In addition to the annotations 
provided by the NCBI and IMG platforms, which included Pfam, COG, TIGRFam, KO, 
EC, secretion signals and transmembrane domains, we also analyzed the predicted 
proteins and their functions through MetaCyc, eggNOG and TransportDB. For metabolic 
reconstruction we combined the use of the IMG networks, KEGG-BlastKOALA, and 
MetaCyc-Pathway Tools with individual gene searches (blast and hmmsearch), sequence 
alignments, and phylogenetic reconstruction using homologues from related sulfate 
reducers, acetogens, or human microbiome bacteria. Sequence alignments were 
performed using Muscle and maximum likelihood phylogenetic reconstructions were 
based on PhyML or FastTree, all implemented in Geneious. Genomic alignments were 
displayed using Circos (180). 
Pro-inflammatory cytokine secretion assays. Late log cultures of D. oralis 
grown under pyruvate fermentation condition (50 mL, three replicates) were chilled on 
ice, and spun by centrifugation (4°C 10,000 x g for 10 minutes). The cell pellets were 
flash-frozen at -80°C and the spent medium was passed through a 0.22μm Millipore filter 
and frozen at -20°C. 
Immortalized human oral keratinocytes (OKF6/TERT-2) were grown on 
keratinocyte-SFM 1X medium (Invitrogen, Carlsbad, CA) supplemented with epidermal 
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growth factor (0.3 ng/mL), bovine pituitary extract (50 μg/mL), 1 IU/mL penicillin and 1 
μg/mL streptomycin to reach ~50% confluence, in 12-well tissue culture plates (Corning 
Inc., Corning, NY, USA) pre-coated with 3 mg/mL collagen (Stemcell Technologies, 
Vancouver, Canada). To each well we added 100l of (a) D. oralis filtered spent medium 
(100l), (b) D. oralis cells re-suspended in keratinocyte medium, (c) fresh D. oralis 
medium, or (d) fresh keratinocyte medium (negative controls), each in triplicate for every 
triplicate D. oralis biological sample. Keratinocytes were incubated for 48 hours at 37°C, 
after which media samples were collected, clarified by centrifugation, and frozen in 
aliquots at -20°C. Cytokine concentrations were measured with the LEGENDplexTM 
human inflammation panel (13-plex)(BioLegend®, San Diego CA, USA) following 
manufacturer’s instructions, using a Cytopeia Influx flow cytometer (BD, Franklin Lakes, 
NJ, USA). Statistical analysis was performed using GRAPHPAD PRISM Version 7. One-
way analysis of variance (ANOVA nonparametric) with Tukey correction was used to 
investigate significant differences between independent groups of data. Statistical 
differences were considered significant at p <0.05. 
Whole cell and secreted proteome data acquisition. Samples from the same 
three replicate D. oralis cultures used for the pro-inflammatory assay were also used for 
proteomic analysis, conducted as detailed in (181). Cell pellets were resuspended in 4% 
sodium deoxycholate (SDC) in 100 mM ammonium bicarbonate (ABC) and ultrasonically 
disrupted. The crude protein extract was clarified by centrifugation, reduced with 10 mM 
dithiothreitol (DTT), and cysteine residues blocked with 30 mM iodoacetamide (IAA). The 
proteins were then collected on top of a 10 kDa cutoff spin column filter. D. oralis spent 
culture medium samples (~12 mL) were concentrated on a 5 kDa filter. Collected proteins 
were washed with ABC and digested with sequencing-grade trypsin (Sigma). Peptides 
were collected by centrifugation, acidified to 1% formic acid (FA) followed by extraction 
with ethyl acetate and concentrated. The peptide mixture was analyzed by automated, 
two-dimensional liquid chromatography tandem mass spectrometry (2D-LC-MS/MS) 
system (181) using Ultimate 3000 RS system in-line with Q Exactive Plus (QE+) mass 
spectrometer (ThermoFisher Scientific).  
Proteomic analyses. All MS/MS spectra were searched against a constructed 
FASTA database containing all proteins predicted from the sequenced genome of 
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Desulfobulbus oralis, concatenated with common contaminants and reversed-decoy 
sequences using Myrimatch version 2.2 (182). Peptides were identified and proteins 
inferred using IDPicker version 3.1 (183) with an experimental false discovery rate (FDR) 
<1% at the peptide level. Peptide abundances were derived in IDPicker by extracting 
precursor intensities/area-under-the-curve from chromatograms with the following 
parameters: retention time of ±90 s and mass tolerance of ±5 ppm. Protein abundances 
were calculated by summing together intensities of all identified peptides and normalized 
by their respective protein lengths. Protein abundances were log2-transformed and 
median-centered across all samples in InfernoRDN version 1.1 (184).  
To investigate enriched secreted proteins, we performed Student’s t-tests between 
the cell pellet and the spent medium (supernatant) samples using Perseus software 
platform (185). We limited the comparison to those proteins observed in all supernatant 
experiments to better focus on proteins that could be secreted and/or induce inflammatory 
response. Proteins with missing values were imputed from a normal distribution (width = 
0.3, shift = 1.8). A protein was considered as significantly enriched in the supernatant if it 
passed the threshold of Benjamini-Hochberg FDR < 0.01 and log2 fold-change greater 
than 2 in the comparison of supernatant versus cell pellet.   
Metatranscriptomic data analysis. MiSeq data for 10 healthy subjects and 6 with 
periodontitis (178) was downloaded from MG-RAST 
(http://metagenomics.anl.gov/linkin.cgi?project=5148). The reads were mapped to the D. 
oralis genome with bowtie2 v. 2.2.6 (with parameters: --very-sensitive-local --no-unal -X 
1000 --score-min G,20,28 --no-mixed --rg-id). The resulting sam files were converted and 
sorted with samtools 0.1.19, alignments were inspected with IGV 2.3.55, and mapping 
was quantitated with htseq-count v. 0.6.1p1. Code used is available at 
https://github.com/cliffbeall/Doralis-metatrans.  
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Figure A2.1. Phylogenetic analysis (FastTree) of selected horizontally-acquired genes in 
D. oralis. Closest sequence homologues from other bacteria (based on Blast) were used. 
For most genes proposed to have been horizontally acquired there were no close 
homologues in other Desulfobulbus genomes. The numbers indicate node support.   
Figure S1. Phylogenetic analysis (FastTree) of selected horizontally-aquired genes in D. oralis.
Closest sequence homologues from other bacteria (based on Blast) were used. For most genes 
proposed to have been horizontally aquired there were no close homologues in other Desulfobulbus
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Figure A2.2. Cytokine stimulation in oral epithelial keratinocytes by Desulfobulbus oralis 
supernatant. Keratinocytes were incubated with D. oralis supernatant for 48h and 
cytokine stimulation was measured using Biolegend LEGENDplex multiplex beads. Each 
bar represents  standard deviation of the mean of triplicate measurements of mean 
technical duplicates. Significantly different from D. oralis medium-only control under 



















































































































































































































































Supplementary Figure 2 | Cytokine stimulation in oral epithelial 
keratinocytes by Desulfobulbus oralis supernatant. Keratinocytes were 
incubated with D. oralis supernatant for 48h and cytokine stimulation 
was measured using Biolegend  LEGENDplex    multiplex beads. Each bar 
represents ± standard deviation of the mean of triplicate measurements 
of mean technical duplicates. Significantly di fferent from   D. oralis 
medium-only control under fermentative conditions (lacking sulfate): 
























Figure A2.3. Cytokine stimulation in oral epithelial keratinocytes by Desulfobulbus oralis 
cells. Keratinocytes were incubated with D. oralis supernatant for 48h and cytokine 
stimulation was measured using Biolegend LEGENDplex multiplex beads. Each bar 
represents  standard deviation of the mean of triplicate measurements of mean technical 
duplicates. Significantly different from keratinocyte medium-only control: * p < 0.05, ** p 




Supplementary Figure 3.  Cytokine stimulation in oral epithelial 
keratinocytes by Desulfobulbus oralis cells. Keratinocytes were incubated 
with D. oralis cells for 48h and cytokine stimulation was measured using 
Biolegend  LEGENDplex  multiplex beads. Each bar represents ± standard 
deviation of the mean of triplicate measurements of mean technical duplicates. 
Signifcantly different from keratinocyte medium-only control: * p < 0.05; 










































































































































































































































































CHAPTER THREE - A step towards elucidating the growth promoting 
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Abstract 
Periodontitis is the leading cause of tooth loss worldwide. Moreover, it has a 
complex etiology originating from within the human oral microbiome. Some of the 
periodontal pathobionts have been identified but many disease-associated lineages 
remain uncultured, in part due to not yet understanding what these microorganisms may 
require for growth in the laboratory. Cultivation is important because it provides the 
opportunity to test specific hypotheses that can tease apart correlation vs. causation in 
disease studies.  Some oral microorganism have been shown to be dependent on 
Fusobacterium nucleatum for growth (39-41, 121). However, it remains unknown what 
molecules produced by F. nucleatum stimulate the growth of other oral species. Using 
the culture system between the recently isolated Desulfobulbus oralis and F. nucleatum, 
we began to investigate what results in the strict requirement of D. oralis for F. nucleatum 
by-products for growth in pure culture to occur. Understanding the relationship between 
D. oralis and F. nucleatum and what D. oralis may require from F. nucleatum for growth 
could allow for the cultivation of more disease-associated bacterial lineages. Using 
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metabolomics, we began to elucidate the metabolic by-products of F. nucleatum growth 
as a step towards uncovering the growth requirements of D. oralis. 
 
Background 
 Within the human oral cavity, great strides have been made in culturing the diverse 
array of microorganisms present there. The human oral cavity is home to over 770 
species-level taxa (14) and has evolved to exist in complex biofilms/communities that 
have resulted in genome reduction and strict interspecies interactions (50). As a result, 
many bacteria remain recalcitrant to cultivation until such dependencies can be identified. 
We recently cultured the first oral Desulfobulbus, D. oralis, and showed a dependency of 
D. oralis on F. nucleatum for growth in pure culture to be maintained (186). Although this 
interaction has been seen before (39-41), it still remains unknown what is produced by F. 
nucleatum that stimulates the growth of other oral species. Understanding the relationship 
between D. oralis and F. nucleatum and what D. oralis may require from F. nucleatum for 
growth could allow for the cultivation of more bacteria and disease-associated bacterial 
lineages. Additionally, understanding how such species interactions have developed can 
shed light on how host microbiomes have evolved.  
We used the D. oralis-F. nucleatum culture system to begin to investigate the 
metabolic by-products of F. nucleatum growth to try and determine the basis of this 
dependency. We began by optimizing a chemically defined medium (CDM) that supports 
the growth of F. nucleatum and determined that this medium alone could not support 
growth of D. oralis. We then sought to identify the metabolic by-products of F. nucleatum 
and further fractionated the resulting supernatant for further analysis via mass 
spectrometry. We tested the effect of these individual fractions on D. oralis growth and 
began to build hypotheses about what may result in the inability of D. oralis to grow in the 
absence of F. nucleatum.  
 
Results and Discussion 
Optimization of a chemically defined medium for growth of Fusobacterium 
nucleatum. Desulfobulbus oralis was originally isolated along with a co-isolated strain of 
Fusobacterium nucleatum animalis (186). A cell-free-supernatant (CFS) following F. 
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nucleatum growth also supports growth of D. oralis in lab media. Further characterization 
identified that F. nucleatum nucleatum ATCC 25586 also supported growth of D. oralis 
and was therefore used for the purpose of these tests as it is a well characterized, whole-
genome-sequenced reference strain of F. nucleatum. Standard growth conditions for F. 
nucleatum involve rich media (e.g. ATCC 1490, modified chopped meat medium). 
However, the very high chemical complexity of such media makes it difficult to identify the 
compounds F. nucleatum secretes as a result of its metabolism. Therefore, we selected 
a chemically defined medium (CDM), previously reported for the growth of oral bacteria 
(187, 188). F. nucleatum grows in that medium under continuous culture conditions (189, 
190). To improve the growth in batch cultures we made some modifications: decreasing 
the levels of reducing agents and buffers and selecting glucose instead of amino acids 
as the primary energy source. The final CDM included amino acids, nucleotides, and 
vitamins (Table 3.1) and supported F. nucleatum growth similar to rich media.  
Fusobacterium grown in chemically defined medium supports the growth of 
Desulfobulbus oralis. Although F. nucleatum in CDM paralleled that in complex media, 
it was unknown if in the CDM F. nucleatum produced the metabolite(s) required by D. 
oralis. We tested samples from a batch culture of F. nucleatum over 70 hours of growth, 
spanning the various growth stages (lag, early and late exponential and stationary 
phases) (Figure 3.1). Cell-free-supernatants (CFS) prepared (as detailed in (186)) from 
those samples were supplemented (10% v/v) into D. oralis cultures and growth was 
measured by OD600 (Figure 3.2). D. oralis growth was induced by F. nucleatum CFS from 
early culture stages (6 hours) and peaked around 27 hours when exponential phase was 
reached. The CDM itself did not support the growth of D. oralis suggesting that F. 
nucleatum secretes a metabolite distinct from the standard amino acids, nucleotides or 
vitamins present in the medium.  
Metabolomics analysis of Fusobacterium cell-free-supernatant by GC-MS. 
Passing all CFS through a 3kD filter did not remove its growth promoting characteristic, 
suggesting that compound(s) required by D. oralis is not a macromolecule. To begin 
characterizing the small molecule metabolites produced by F. nucleatum we analyzed 
CFS from mid-log cultures (OD600 = 0.46) by gas chromatography mass spectrometry 




Table 3.1. Composition of the chemically defined medium (CDM). 
Components Concentration Amino Acids Concentration 
Glucose 15mM Glutamic acid 2mM 
NaCl 200M Histidine 2mM 
CaCl-2H20 150M Lysine 2mM 
MnSO4 60M Leucine 8.75mM 
MgSO4 1.66mM Alanine 2.55mM 
NaCitrate 1mM Arginine 1.31mM 
FeSO4 66M Asparagine 1.72mM 
Na2MoO4 700nM Aspartic Acid 1.72mM 
K2HPO4 5mM Cysteine 1.88mM 
Na2HPO4 5mM Glutamine 1.56mM 
K2CO3 8mM Glycine 3mM 
(NH4)2SO4 4.5mM Myo-inositol 1.26mM 
  Isoleucine 1.74mM 
Vitamins Concentration Methionine 1.53mM 
Folic acid 250nM Phenylalanine 1.38mM 
Pyridoxine hydrochloride 2.5M Proline 2mM 
Riboflavin 650nM Serine 2.17mM 
Biotin 500nM Threonine 1.9mM 
Thiamine 959nM Tryptophan 1.1mM 
Nicotinic acid 2M Tyrosine 1.26mM 
Calcium Pantothenate 500M Valine 1.95mM 
Vitamin B12 1nM Nucleotides Concentration 
p-Aminobenzoid acid 4M Guanine 175M 
Thioctic acid 1M Uracil 275M 







Figure 3.1. Growth of Fusobacterium nucleatum on chemically defined medium (CDM). 
Red diamonds indicate points of growth where cell-free-supernatant (CFS) was collected 
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Figure 3.2. Growth of Desulfobulbus oralis after supplementation with CFS collected at 
times 0, 6, 21, 27, and 46 hours of F. nucleatum growth. Growth curve is representative 
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identify peaks (metabolites) unique to the CFS. The results from GC-MS detected the 
presence of cadaverine, cystine, 2-hydoxybutyric acid, and 2-hydroxyglutaric acid 
(Figure 3.3) as well as three unknowns not present in the CDM. Based on these findings, 
we tested pure 3-indolebutyric acid, gamma-aminobutyric acid (GABA), cystine, 2-
hydoxybutyric acid, 2-hydroxyglutaric acid, 2-ketoglutaric acid, and 2-ketobutyric acid for 
growth support of D. oralis. A mixture, as well as individual compounds, were added to 
D. oralis cultures at varying concentrations to determine whether they could stimulate 
growth. None of the amendments led to D. oralis growth. 
 Chemical fractionation of F. nucleatum CFS. To reduce the complexity of the 
CFS we applied organic phase extraction by using ethyl-acetate and methanol solvent 
extractions. A total of 14 fractions were collected and tested as to whether or not they 
supported D. oralis growth (Figure 3.4). The ethyl-acetate extractions showed the biggest 
degree of variability between the samples with fraction 2 (EtAc2) stimulating growth to 
native growth densities (Figure 3.4a). Fractions 3 and 4 (EtAc3 and EtAc4) showed the 
most similar growth stimulation to that of the positive control while EtAc1 was most 
comparable to the negative control sample suggesting growth stimulation did not occur in 
that fraction. The alkaline and acidic methanol extractions showed less variability when 
compared to each other (Figure 3.4c,d) with all fractions supporting growth to varying 
degrees. As we wanted to target a distinct fraction that supported growth relative to the 
others, we focused on ethyl-acetate fraction 2 (EtAc2). We analyzed fraction EtAc2 via 
GC-MS and identified a single pronounced peak for 2-hydroxybutyric acid.  
 Ongoing experiments are testing pure 2-hydroxybutyric acid in combinations with 
amino acids and vitamins to determine whether this compound is capable of stimulating 
D. oralis growth in the absence of F. nucleatum. Additionally, as GC-MS may miss some 
compounds, we are analyzing EtAc2 via liquid chromatography mass spectrometry (LC-
MS) and nuclear magnetic resonance (NMR).  
 
Conclusions 
 The recent cultivation of Desulfobulbus oralis provides a novel platform with which 
to further understand how such organisms have evolved and became dependent on other 





Figure 3.3. Example extracted ion chromatograms from GC-MS for the presence of 2-













































Figure 3.4. Growth of D. oralis on the various CFS extractions. a. Ethyl-acetate (EtAc) 
extractions 1-4 (see methods) as compared to a CFS dehydrated positive control (supe 
+) and a no additions negative control (minus additions). b. Alkaline methanol (Alk) 
extractions for flow-through (FT), wash 5% (W5), 20%, 40%, and 80% methanol as 
compared to a no additions negative control. c. Acidic methanol (Ac) extractions for flow-
through (FT), wash 5% (W5), 20%, 40%, and 80% methanol as compared to a no 



























































other, and with the human host, will provide insights into what results in microbial 
“unculturability”. As periodontal disease is a result of a community shift favoring specific 
microorganisms, understanding these microbe-microbe interactions can shed light on 
what may trigger a dysbiotic environment. Here we made strides in understanding the 
metabolic signature of Fusobacterium nucleatum and what may result in the stimulation 
of other oral bacteria. 
 
Materials and Methods 
Microbial Cultivation. Pure cultures of D. oralis were grown in a modified Lactate-
Baar medium containing (L-1 distilled water): 2g MgSO4.7H2O, 1g (NH4)2SO4, 10mM 
MOPS, 10mM HEPES, 10mM sodium lactate, 0.1% yeast extract, 2.5mM cysteine, and 
0.5 mg resazurin 0.5%. The pH of the media was adjusted to 7-7.1 with 8M NaOH, 
degassed with N2 (100%) and autoclaved for 30 minutes at 121°C in balch tubes fitted 
with butyl rubber stoppers. After cooling, sterile K2HPO4 (0.5M, pH 7) was added to 3mM 
final. F. nucleatum was grown in either BHI autoclaved or CDM (Table 3.1) (amino acids 
and vitamins were prepared using synthetic amino acids supplements (Y1501, Sigma) 
and a vitamin mix (ATCC MD-VS)) pH 7.3. filter-sterilized with 0.22μm NalgeneTM 
Rapid-FlowTM sterile filters, both under 85%N2, 10%CO2, 5%H2. F. nucleatum cell-free-
spent supernatant (CFS) was prepared by filtering cultures through two 0.22μm 
NalgeneTM Rapid-FlowTM sterile filters and degassing with N2 (100%) and 1mM cysteine 
was added to keep it reduced in balch tubes fitted with butyl rubber stoppers and added 
to D. oralis medium 10% v/v. Culture stocks were preserved by freezing at -80°C after 
adding DMSO to 10% (v/v). All OD600 results were measured with either an Eppendorf 
BioPhotometer or a Milton Roy Spectronic 21D fit for balch tubes.  
Physiological analyses. Preliminary metabolite tests were performed with L-
alpha-hydroxyglutaric acid disodium salt, 2-hydroxybutyric acid sodium salt (97%), L-
cystine dihydrochloric acid, indole-3-butyric acid, 2 ketobutyric acid, 2 ketoglutaric acid, 
and gamma-aminobutyric acid (Sigma-Aldrich). Hydroxybutyric acid, hydroxyglutaric 
acid, ketobutyric acid, and ketoglutaric acid were prepared at 100mM in water. Indole-3-
butyric acid was prepared at 100mM in 100% ethanol. Cystine (100mM) was prepared in 
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1M HCl. Additions were filter-sterilized, degassed with N2, and added to D. oralis medium 
at 1-2mM, 0.1-0.2mM, and 0.001-0.002mM and pH was controlled by MOPs.  
Ethyl-acetate extractions were prepared by adding F. nucleatum CFS (neutral pH) 
to ethyl-acetate (EtAc) and mixing vigorously. Samples were spun at 2000 x g for 2 
minutes to facilitate separation. Top fraction was recovered (EtAc1). Remaining aqueous 
solution was acidified with HCl to pH 4.5 and EtAc was added to this and mixing and 
spinning was repeated. Top fraction was recovered (EtAc2) and bottom phase (EtAc3). 
Remaining aqueous phase was acidified to pH 2.3 and further extracted with EtAc by 
mixing and spinning as above (EtAc4). Solvent was removed from samples using a speed 
vac and either directly prepared for mass spectrometry or resuspended in CDM and 
brought to neutral pH, filter-sterilized, degassed with N2, and added to D. oralis medium 
at 10% v/v. 
Methanol extractions were prepared by using a Sep-Pak C18 plus short cartridge 
(360mg Sorbent per Cartridge) product #WAT02515. F. nucleatum supernatant was split 
into two equal portions, one was acidified with HCl to pH 2.2 and the other was made 
alkaline with KOH to pH 10. Each was then processed for fractions. Solutions of methanol 
were prepared: 5%, 20%, 40%, 80% in molecular grade water solutions. Using 10ml 
syringes, the columns were first slowly washed with 100% methanol to remove impurities 
and to wet the column. Then the columns were equilibrated with a 5% methanol solution. 
Sample was then slowly passed through the filter and collected (Ac or Alk flow-through 
or FT). Then, another 5% methanol wash was passed through the filter and collected (Ac 
or Alk wash 5% or W5). Then the different percentages of methanol were used to elute 
(20->40->80 Ac or Alk 20/40/80"). Solvent was removed from samples using a speed 
vac and either directly prepared for mass spectrometry or resuspended in CDM and 
brought to neutral pH, filter-sterilized, degassed with N2, and added to D. oralis medium 
at 10% v/v. 
Cellular and molecular analyses. To monitor cultures, 16S rRNA gene 
sequencing was used throughout to confirm purity of the cultures. DNA was extracted 
using a Zymogen Research fungal/bacterial DNA MiniPrep kit and PCR-amplification was 
carried out using the universal primer set 27F (5’-AGAGTTTGATYMTGGCTCAG-3’) and 
1492R (5’-TACGGYTACCTTGTTACGACTT-3’). Amplification with EconoTaq 
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(Lucigen©) used the following thermal profile: 95°C for 3 minutes, followed by 32 cycles 
of 95°C for 30 seconds, 56°C for 45 seconds, 72°C for 90 seconds, and a final extension 
of 72°C for 5 minutes. Single band products were directly sequenced at Eurofins 
Genomics (Louisville, KY, USA) using Sanger chemistry. 
GC-MS analyses. For GC-MS, 15 µL of sorbitol (1 mg/mL) was added as an 
internal standard to a 50 µL aliquot of sample and then dried under a stream of nitrogen. 
Following evaporation, trimethylsilyl derivatives were generated by dissolving the dried 
sample residue in 0.5 mL of silylation–grade acetonitrile followed by addition of 0.5 mL of 
N-methyl-N-trimethylsilyltrifluoroacetamide with 1% trimethylchlorosilane (Thermo 
Scientific, Bellefonte, PA) and heating for 1 hour. A 1 µL aliquot of the trimethylsilyl 
derivatives solution was injected into an Agilent Technologies Inc. (Santa Clara, CA) 
5975C inert XL gas chromatograph-mass spectrometer (GC-MS) fitted with an Rtx-5MS 
with Integra-guard (5% diphenyl/95% dimethyl polysiloxane) 30 m x 250 µm x 0.25 µm 
film thickness capillary column. The quadrupole GC-MS was operated in the electron 
ionization (70 eV) mode with 6 full-spectrum (50–650 Da) scans per second; gas (helium) 
flow was set at 1 mL/min with the injection port configured in the splitless mode. The 
injection port, MS source, and MS quad temperatures were set to 250 °C, 230 °C, and 
150 °C, respectively. The initial oven temperature was held at 50 °C for 2 min and was 
programmed to increase at 20 °C per min to 325 °C, to hold for 11 min, and then to return 
to the initial 50 °C hold. Peaks were assigned using a custom mass spectral database, 





CHAPTER FOUR - Targeted isolation and cultivation of microbial 
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Abstract 
The vast majority of microorganisms, across all taxonomic levels, have remained 
uncultured. Single cell genomes and metagenomes are expanding the known diversity of 
Bacteria and Archaea and have facilitated inferences of potential physiological and 
environmental roles, but most are not experimentally validated. Ideally, sequence data 
should enable targeted microbial isolation, cultivation, and characterization. Here we used 
genome-informed antibody engineering to selectively isolate single cells, cultivate 
previously “unculturable” bacteria, and identify novel symbioses. By targeting the 
candidate phylum TM7 (“Saccharibacteria”) from the human oral microbiota, we 
sequenced genomes representing 8 distinct lineages. Viable cell isolation enabled 
cultivation of three different species-level lineages of oral TM7 as epibionts on diverse 
Actinobacteria, demonstrating that this approach can lead to discovery and 
characterization of novel interspecies partnerships. As the concept could be applied to 
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any group of microorganisms, from any environment, it unlocks the potential to directly 
isolate, culture, and characterize representatives of the yet-uncultured branches of the 
microbial tree of life.  
 
Introduction 
Our understanding of the microbial tree of life has undergone continuous reshaping 
and refinement ever since the introduction of molecular, culture-independent methods to 
identify and classify organisms. While pre-genomic, ribosomal RNA gene sequencing 
resulted in the discovery of nearly two dozen candidate Bacteria and Archaea phyla (191), 
more recent single-cell genomic and metagenomic assemblies (SAGs and MAGs) have 
led to a deluge of proposed novel lineages (27, 192-194). Notably, however, SAGs and 
MAGs of specific, target taxa are generally retrieved by chance, depending on their 
abundance in the community and currently there are no effective ways to focus on 
specific, individual taxa. Furthermore, although microbial cultivation has been successful 
for representatives of a handful of phyla initially discovered by rRNA sequencing, the vast 
majority of candidate microbial taxa remain uncultured. Genome-based metabolic 
reconstructions can provide important insights into the lifestyle and characteristics of 
various uncultured Bacteria and Archaea but, with few exceptions, have not led to 
targeted isolation of novel microbes (164, 195). Growth requirements of many organisms 
may be too complex, or too subtle, for genomic-based predictions and may depend on 
specific interspecies interactions (e.g. Nanoarchaeota (164, 196, 197), 
TM7/”Saccharibacteria” (45)).  High-throughput cultivation approaches, multispecies 
consortia, and addition of various growth factors have been used successfully to 
propagate and isolate “unculturable” organisms from various environments including 
soils, water, sediments, and the human microbiome (41, 198-202). However, being able 
to directly link the genotype to actual cells while maintaining cellular viability would enable 
isolation of cells from target microbial taxa for selective genomic sequencing or cultivation 
and characterization of interspecies interactions. Here we introduce such an approach, 
using antibodies against predicted cell surface protein epitopes from uncultured bacteria, 
with human oral TM7/"Saccharibacteria” as a test case (Figure 4.1a).   





Figure 4.1. Overview of targeted microbial isolation through reverse genomics. a. 
Diagram showing the steps in reverse genomics-enabled microbiology: (1) Identification 
of membrane protein-encoding genes in SAGs and MAGs, (2) selection of predicted 
exposed epitopes, (3) antibody production, (4) purification and fluorescent labelling, (5) 
staining of target cells from microbiome samples (6) and isolation for genomic sequencing 
(7) or cultivation (8). b. X-ray structure of penicillin-binding protein from E. coli, with the 
modeled TM7 glycosyltransferase (GT) domain colored blue and the selected epitope 
region highlighted in yellow-brown. c. Structural model of TM7a capsular polysaccharide 
















TM7 was one of the first candidate bacterial phyla proposed two decades ago 
based on rRNA gene sequences (76, 203) and was subsequently detected in a wide 
range of environments, including in association with plants and animals. Following 
metagenomics-based genomic assembly of near-complete genomes for several TM7 
lineages from activated sludge, the group has been renamed “Saccharibacteria” (44) 
(204), although as a formal classification and valid description are still lacking. In humans 
approximately a dozen distinct species-level TM7 are recognized (205), mostly in the oral 
cavity, and their increased abundance has been correlated with the development of 
periodontitis (206) and inflammatory bowel disease (74). Related lineages have also been 
identified in dogs, cats and dolphins (127, 207, 208). The first genomic data for a human 
oral TM7 was generated by single-cell sequencing following micro-isolation from 
supragingival plaque (28). Recently, the first TM7 bacterium (TM7x) was cultured as an 
obligate epibiont on the human oral Actinomyces odontolyticus, based on serendipitous 
streptomycin resistance (45). Considering the large taxonomic diversity and ubiquitous 
environmental presence of these organisms, generally at low abundance (<1%), we 
selected TM7 for developing reverse genomics-enabled microbial isolation.  
  
Results 
 Selection of TM7 bacterial cell surface antibody targets. We used the first 
single-cell genomic data from a human oral TM7 (TM7a)(28) to identify genes encoding 
predicted membrane-associated proteins for which function could be inferred, based on 
homologues from other bacteria. We avoided hypothetical proteins, because in the 
absence of gene expression information we considered those less likely to be present on 
the cell surface. It should be noted, however, that if experimental data (e.g. based on 
metaproteomics, metatranscriptomics) would be available, any categories of membrane 
protein could be a potential target. We then screened for proteins with extracellular 
domains that could be used as antigens for antibody development and which had 
homologues with solved three-dimensional structures. A candidate protein that satisfied 
these criteria was a predicted penicillin-binding protein (PBP2). In pathogenic bacteria, 
PBP2 has been shown to be an effective vaccine target, indicating that the protein is 
expressed and can be recognized by an antibody (209). Crystal structures for 
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Staphylococcus aureus (PDB entry 3DWK) and Escherichia coli (3VMA) protein 
homologs were used to model the TM7a PBP2 and identify potentially exposed epitopes. 
PBP2 is anchored in the membrane by a single -helix and consists of two extracellular 
domains, an N-terminal glycosyltransferase (GT) domain and a C-terminal transpeptidase 
(TP) domain connected by a -rich linker region (210) (Figure 4.1b). A 19-amino acid 
sequence located in the GT domain was selected as antigen based on surface exposure, 
predicted immunogenicity and solubility, and was used for raising polyclonal antibodies 
(Figure A4.1) (all additional material occurs in the chapter appendix).  As experimental 
structure data for membrane proteins is relatively scarce, computational prediction may 
also be used for antigen selection. Capsular polysaccharide biosynthesis protein (CpsC) 
was selected as second target but it lacked close homologues with solved structures. We 
generated a Rosetta 3D structure model using coevolution-derived residue-residue 
contact restraints (211), and a predicted antigenic peptide from an extracellular -helical 
domain was used to raise antibodies. 
 While for this study we selected short peptides, entire protein domains could be 
used as antigens for generating polyclonal antibodies. Such antibodies would target 
multiple regions of the membrane protein and could increase the chance of binding, 
especially if some residues may be sterically hindered (e.g. due to glycosylation). 
However, depending on the degree of sequence conservation, antibodies raised against 
protein domains may be less specific and bind to bacteria other than the target group.   
Antibody-enabled isolation and cultivation of oral TM7/Saccharibacteria 
symbiotic lineages. Human oral samples (saliva, subgingival fluid) from orally healthy 
donors and from patients with periodontitis were incubated with fluorescently labeled anti-
PBP2 and anti-CpsC IgGs (anti-TM7). Stained samples were analyzed by flow cytometry, 
revealing a distinct population of fluorescent cells (0.1-5%, depending on the sample) 
(Figure 4.2a, b). To determine if Saccharibacteria were labeled by the antibody, we 
sorted pools of 10-100 fluorescent cells followed by multiple displacement genomic 
amplification (MDA). We then assayed for the presence of TM7 bacteria using PCR with 
specific primers targeting the small subunit ribosomal RNA (SSU rRNA) gene followed by 
Sanger sequencing or by MiSeq amplicon sequencing of the V4 region of the SSU rRNA 




Figure 4.2. Isolation of TM7 cells by flow cytometry cell sorting. a-b. Flow cytometry plot 
(forward scatter “FSC” versus green fluorescence “RFU”) of native (a) and TM7 antibody-
labelled oral samples (b). The sort gate area indicates selection characteristics for cell 
sorting. Highly fluorescent particles (RFU>103) are auto fluorescent 
precipitates/minerals. c. Microbial diversity in pools of 10 sorted cell pools, following MDA 
and 16S rRNA gene amplicon sequencing. Also shown for comparison is the diversity of 
the original subgingival samples (far right column). d. Maximum likelihood tree of human 
oral TM7 SSU rRNA sequences, indicating phylotypes retrieved by antibody labeling and 
cell sorting (blue dots) and TM7 groups (G1-G6). Circles at nodes indicate bootstrap 




for TM7, depending on individual subjects/samples and gating parameters, with both anti-
PBP2 and anti-CpsC successfully retrieving TM7 cells. To enhance the fluorescence 
signal through dual labelling and to cover as much as possible of sequence variation 
space, most experiments were subsequently performed with a mix of the two antibodies. 
As such, when we analyzed the pools for taxonomic representation, 
Saccharibacteria/TM7 comprised up to 95% of the sequences and represented 
phylotypes from groups 1, 3 and 6 (Figure 4.2c, d and Figure A4.2). Other bacteria were 
primarily members of Fusobacteria, Actinobacteria, Bacteroidetes, Haemophilus and 
Streptococcus. The identification of species other than the target TM7 bacteria may 
indicate cross-reactivity of the antibodies, free genomic DNA, and interspecies cellular 
adhesion (specific or non-specific) which is extensive in the microbiota (212).  
We demonstrated that the anti-TM7 peptide antibodies can label target cells in 
biological samples and enable their isolation by flow cytometry. We tested if cell isolation 
could then be viable and propagate in cultures. Importantly, such cultures would enable 
identification of potential physiological interactions between various TM7 lineages and 
other bacteria in the oral microbiota. Using freshly collected oral samples, we labeled the 
bacteria with the anti-TM7 antibodies and sorted individual fluorescent particles (cells) on 
culture media. Following incubation under anaerobic or hypoxic conditions, the cultures 
were tested for the presence of TM7 bacteria using rRNA gene amplicon sequencing.  
On solid media, we identified colonies containing five distinct TM7 phylotypes 
(species to family/order taxonomic range), HOTs 346, 348, 352, 952/TM7x (all group 1) 
and HOT 351 (group 3) (Figure 4.3, Figure A4.3). Based on amplicon sequencing, most 
TM7 positive colonies also contained species of Actinobacteria and some also contained 
Streptococcus. This finding suggested that Actinobacteria may be host organisms, as 
with TM7x, and that Streptococcus cells, known to be highly adherent (213), are co-
isolates. Surprisingly, TM7 HOTs 346 and 348 (distinct species, based on 93% rRNA 
identity), were identified in the same colony with Cellulosimicrobium cellulans, an 
actinobacterium present in healthy saliva but occasionally associated with bacteremia 
and other diseases (214). As the fluorescent particle could not have contained multiple 
Cellulosimicrobium cells that independently also harbored different TM7, multiple epibiont 











Figure 4.3. Diversity of cultivated and uncultivated TM7 bacteria. a. Maximum-likelihood 
phylogenies of TM7 bacteria and of selected human oral Actinobacteria, based on small 
subunit rRNA genes. TM7 bacteria include human oral phylotypes (HOTs) as well as 
related host-associated lineages from open environments, identified by sequence 
accession numbers and associated with six operational groupings (G1-6). HOTs detected 
using antibodies, isolated as single cells, or identified in cultures are indicated by colored 
stars. Circles at nodes indicate bootstrap support (>80% filled, 50-80% open, only shown 
for major groupings). Lines connecting TM7 and Actinobacteria species indicate epibiont-
host systems identified previously (blue highlight) and in this study (green). b. 
Epifluorescence microscopy images of novel TM7-host associations identified in this 
study using immunolabeling (TM7 HOT351-Actinomyces HOT897 and TM7 HOT346-
Cellulosimicrobium cellulans) or FISH (TM7352-Actinomyces odontolyticus strain OR). 








labeling and cell sorting resulted in a pure co-culture of C. cellulans-TM7 HOT346. In a 
separate experiment using an oral sample from the same donor, a second TM7 HOT346 
strain was co-isolated with Actinomyces sp. HOT171. This represents the first 
demonstration that in their natural environment (oral microbiota) a TM7 species can be 
an epibiont on bacteria that belong to distinct genera.  
 TM7 HOT351 is the first cultivated member of a novel family to order-level 
TM7/Saccharibacteria taxon (85% 16S RNA identity to TM7x) and was identified in pure 
co-culture with a previously uncultured Actinomyces species (A. sp. HOT897), most 
closely related to A. dentalis (92% identity). As characterization of all human oral bacteria 
has been a continuous effort over decades, the isolation of a novel species of 
Actinobacteria further highlights the importance of novel approaches in enabling co-
cultivation of interacting organisms that were refractory to traditional methods. 
For two closely related phylotypes, TM7 HOT352 and HOT952, which belong to 
the same species complex as TM7x, we identified the host as Actinomyces odontolyticus 
XH001, the known host of TM7x (45). In liquid microcultures we also detected TM7 
HOT347 (Group 1) and HOT870 (Group 6) however those cultures could not be 
maintained, and we did not identify the native host of those Saccharibacteria lineages.  
Identification of multiple oral TM7-host pairs provides the first substantial view into the 
evolution of such interbacterial relationships within a candidate phylum.  Interestingly, 
there is no apparent correlation in phylogenetic distance between the 
TM7/Saccharibacteria species and their Actinobacteria hosts, which would indicate co-
speciation (Figure 4.3a). This suggests that the parasite-host interaction evolved 
separately, likely after oral colonization, and were not necessarily linked to speciation 
events. Host specificity appears stringent for TM7x, as closely related Actinomyces 
cannot substitute the strain that it was co-isolated with (45). We have further expanded 
on our understanding of TM7 physiology by identifying cells from distinct TM7 lineages 
that can simultaneously “infect” the same host cell and that the same TM7 species can 
“infect” distinct hosts in vivo. That indicates some flexibility in the establishment of the 
ectosymbiosis. The molecular mechanisms of interaction and the host specificity 
determinants for the different TM7 species and their hosts remains unknown. As other 
members of the “Candidate Phyla Radiation” are hypothesized to have an obligate  
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parasitic/symbiotic lifestyle (215), isolation of additional TM7 and related symbiotic 
systems will be important for better understanding of the evolution of these microbial 
lineages and characterizing the molecular strategies that ectobionts use to attach to host 
cells and obtain metabolic building blocks.  
All TM7 are very small epibiont cocci (<0.5 m in diameter) on the surface of host 
cells, observed using both fluorescence in situ hybridization (FISH) and staining with the 
TM7 antibody (Figure 4.3b). TM7 HOT351 cells appear primarily associated with the pole 
of the bacillus-shaped Actinomyces host cells, while for the others, there does not appear 
to be a localization preference (46). As with TM7x-A. odontolyticus XH001, we found that 
growth conditions affect the relative abundance of the different TM7 in the co-cultures, 
although each appears to have its own characteristics. Whereas TM7x abundance 
increased in the presence of oxygen, TM7 HOT351 and 346 were inhibited by micro-oxic 
environment as their hosts were also inhibited. The physiology of each TM7 lineage is 
therefore linked to that of their hosts and the subject of ongoing studies for all of the 
symbiotic systems we isolated. 
Antibody-enabled single cell genomics. Because not every organism may be 
readily culturable, we also tested the targeted isolation approach to obtain single cell 
genomic information for the various oral TM7/Saccharibacteria lineages. Targeted 
collection of specific genomes could further provide hypotheses to begin to isolate other 
uncultured lineages of bacteria. Flow cytometry enables analysis of over 5,000 cells per 
second, therefore taxa present at extremely low abundance could be targeted for single 
cell isolation and genomic sequencing.  Labeled samples from healthy individuals and 
from individuals with periodontitis were therefore used for single cell sorting and MDA. 
We identified over two dozen TM7 single-cell amplified genomes (SAGs), which were 
assigned to six human oral taxa, HOT’s 346, 348, 349, 351, 352 and 353/952. SAGs from 
two other TM7 HOTs (350 and 356), identified through un-targeted single-cell isolation 
(32, 34), were also included in the analysis. Unlike genomes derived from metagenomes 
(MAGs), that most often lack rRNA sequences and are difficult to match with lineages 
previously known based on 16S studies, SAGs enable such comparisons. This is 
important for organisms that span a wide taxonomic space (such as the oral 
Saccharibacteria), ranging from species/subspecies to genera and families/orders. In 
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total, we sequenced and assembled 23 of the SAGs, representing four of the six groups 
of TM7/Saccharibacteria in the human oral microbiome (Groups 1, 2, 3 and 5) (Table 
S4.1). The assembled SAGs ranged from 0.25 to 1 Mbp (median 0.62 Mbp), reflecting 
different levels of genome completion (Figure 4.4a, Figure A4.4, and Table S4.1). In 
comparison, the closed genome of TM7x is 0.7 Mbp (45), while MAGs of 
TM7/Saccharibacteria from open environments range between 0.8-1.2 Mbp (44, 47, 193). 
Based on conserved single copy core genes (Table S4.1), we estimated the level of 
completion of the SAGs to be between 40 and more than 90%. The oral TM7 genomes 
share a core of 279 shared orthologous gene families, mostly related to genetic 
information processing, transport and secretion functions. The small genome size, 
especially for oral TM7, is a result of gene (and metabolic capability) loss associated with 
their parasitic lifestyle, which likely extends across all oral phylotypes. However, it is not 
known if TM7 from open environments are dependent on physical association with other 
bacteria.  It has been proposed, based on the interspersed oral and environmental TM7 
lineages, that multiple independent acquisitions of oral microbiota were followed by 
independent genome reductions (and possible bacterial host associations) among the 
TM7 subtypes (216). As humans share close relatives of oral TM7 with other mammals 
(Figure 4.3a and Figure A4.5), oral colonization by these bacteria likely occurred early 
in the evolution of mammals, if not before. A two-fold increase in the abundance of genes 
related to defense mechanisms (CRISPR-Cas, restriction-modification systems and 
putative virulence factors) and a reduction in genes associated with cellular motility and 
redox processes (Figure A4.6 and Table S4.1) are also potentially linked to adaptation 
to a epibiotic lifestyle (45, 208, 216). 
As with other related lineages from the “Candidate Phyla Radiation” (CPR)(27, 
215), genome reduction in TM7/Saccharibacteria has led to the loss of numerous 
functions, including biosynthesis of essential amino acids and vitamins. All TM7 appear 
to have an obligately fermentative metabolism with no respiratory functions, as electron 
transport chains are lacking. None of the TM7 can synthesize sugars by gluconeogenesis, 
as the key enzyme fructose-1,6-bisphosphatase is absent. Glucose and other 
monosaccharides may be fermented via the pentose phosphate and heterolactic 
fermentation pathways. We identified, however significant differences between the  
 
 82 
Figure 4.4. Comparison of oral TM7 at genomic and metabolic levels. a. Alignment of 
oral TM7 genomes using Anvi’o (217, 218), showing basic genome characteristics, 
distribution of core genes and functional gene categories across the various phylotypes. 
b. Reconstruction of central metabolic pathways for TM7 bacteria, based on completed 
genomes and draft SAG/MAG assemblies. Blue or green circles indicate broad presence 
in environmental and animal-associated TM7. Semicircles indicate occasional presence, 
associated with specific environments. Absent reactions are in red. The absence of genes 
encoding the three essential pentose phosphate pathway enzymes in human oral TM7 is 







various types of TM7 based on environmental origin and phylogenetic grouping (Figure 
4.4b). TM7 genomes from open environments encode a nearly complete pentose 
phosphate pathway coupled with heterolactic fermentation, which could generate 
reduced NADPH and ATP via substrate-level phosphorylation by acetate kinase and 
pyruvate kinase.  However, genes encoding two of the enzymes for the terminal part of 
the glycolytic cycle, phosphoglycerate mutase and enolase could not be identified in any 
of the environmental TM7 genomes, although they are present in all oral TM7. On the 
other hand, all human TM7 appear to lack important enzymes for the initial NADPH-
generating reactions of the pentose phosphate pathway and also a key enzyme for 
heterolactic fermentation, xylulose phosphate phosphoketolase. Therefore, oral TM7 may 
use hexose-pentose interconversions and primarily operate glycolysis reactions for ATP 
synthesis. Evidence of several other differential gene (and metabolic potential) loss 
between various lineages of TM7 (acetate kinase, lactate dehydrogenase 
phosphofructokinase and phosphoenol pyruvate synthase), suggests that central 
metabolic pathways have been in continuous reshaping and reflect adaptation to specific 
open environments and oral niches (Figure 4.4b).  
Because TM7 bacteria are auxotrophs for amino acids, nucleotides and vitamins, 
they require efficient uptake mechanisms. Based on comparative genomic analysis of 
host-associated and open environment TM7 genomes we identified only a handful of 
recognizable transporters. Paucity of canonical transport mechanisms has been noted in 
other obligate symbionts (e.g. Nanoarchaeota, insect intracellular endosymbiotic 
bacteria), where  it has been proposed that direct cytoplasmic bridges (219) or specialized 
proteins that change membrane permeability (220) may enable intercellular molecular 
fluxes. In TM7, as in Nanoarchaeota, such transport processes must occur over an area 
only few nanometers across (164). As such ectobionts may be able to detach from their 
host cells and survive free for a limited time, they may have mechanisms to maintain 
some energetic independence (ATP and reducing equivalents) by acquiring specific 
central metabolic substrates directly from the environment. We hypothesized, based on 
the glycolytic pathway predicted in all human oral TM7 (Figure 4.4b), that 
supplementation of the culture medium with glycolysis substrates might stimulate growth 
if they could be utilized directly. As such, we tested media supplemented with 2-5mM 
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additions of glucose, ribose, phosphoenolpyruvate, pyruvate or lactate, singly or in 
combination. However, we did not detect any effect relative to any of the TM7 strains. 
While we cannot conclude TM7 detached from their host cells could not uptake glycolytic 
substrates in vivo, in laboratory cultures they appear to exclusively rely on metabolites 
provided through cell contact with Actinobacteria. In several of the oral TM7 genomes we 
identified the gene encoding a sugar efflux transporter for intercellular exchange 
(PF03083), which, together with proteins containing cell wall binding repeat domains 
(PF01473) might be involved in that process. Ultrastructural studies ultimately will be 
required to better understand how the oral TM7 ectobionts interact with their hosts.    
Reverse genomics for other “unculturable” microbial lineages. While the 
success of using two effective antibodies against TM7/Saccharibacteria is unlikely a result 
of any special features of its proteome, we further sought to test and expand this approach 
to a microbial lineage that currently has no cultured representatives. We selected 
candidate bacterial phylum SR1/”Absconditabacteria”, organisms present at low 
abundance in a variety of environments including in the human oral cavity. SR1 bacteria 
have highly reduced genomes, indicating likely dependence on interacting organism(s), 
and have recoded the opal stop codon (UGA) for encoding glycine (32). Based on single 
cell genomic data of human oral SR1 HOT345, we applied the same search criteria for 
conserved membrane proteins with extracellular domains. We selected a predicted 
surface exposed transglycosylase, also annotated as surface antigen involved in cell wall 
biogenesis (Genbank accession RAL55607). The protein has one predicted 
transmembrane helix and a ~300 amino acids globular extracellular domain. For this 
protein target we selected that entire exposed domain for which gene synthesis, protein 
expression and purification followed by antibody production were performed 
commercially. The resulting antibody has been effective in capturing live SR1 cells from 
human oral samples. Culture enrichments as well as analyses on the binding specificity 
of that antibody on samples from various environments are under current investigation.  
     
Discussion 
Genome sequences have greatly expanded our understanding of microbial 
diversity and evolution. However, the absence of cultured representatives of many 
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lineages still hinders our ability to study the roles numerous lineages of Bacteria and 
Archaea play in their environments and how they interact with others. Here we have 
leveraged single cell genomic data to selectively isolate, using engineered antibodies, 
cells of diverse species of TM7/Saccharibacteria for sequencing and cultivation along with 
their interacting Actinobacteria hosts. As many bacterial and archaeal lineages have no 
cultured representatives and are inferred based on their genomic sequence to depend on 
other members of their communities, cultivation and partnership characterization are 
essential. The causes of microbial “uncultivability” are numerous, and includes 
requirements for specific nutrients and growth factors produced by other species, strict 
interspecies interactions, slow growth, competition/inhibition, and dormancy (221, 222). 
Traditional microbial cultivation approaches are stochastic or rely on selection for specific 
physiological traits. Genomic inferences have occasionally been instrumental in 
enrichment and isolation of several organisms but depend on identifying such traits, which 
rarely allow for selection in complex enrichments and therefore are not universally 
applicable. Physical retrieval of single live cells of target microbial taxa from complex 
communities enables a high throughput search for optimal cultivation parameters and, 
conceptually, could be applicable to any organism for which a suitable surface target can 
be identified. While not every organism may be immediately culturable, single cell 
genomics data from such target cells would further enable population studies, specific 
physiological inferences and may ultimately lead to successful cultivation. Applying and 
further developing this strategy to other yet-uncultured taxa could begin to fill the many 
cultivation gaps in the tree of life.  
 
Methods 
Ethics Statement. Human subjects recruitment and sampling protocols were 
approved by the Ohio State University Institutional Review Board and by the Oak Ridge 
Site-Wide Institutional Review Board. Written informed consent was obtained from all 
participants. The use of commercial custom antibodies was approved by the Oak Ridge 
National Laboratory Animal Care and Use Committee. 
Sample Collection and Processing. Saliva samples were self-collected by 
healthy donors by passive drool, using a SalivaBio collection aid (Salimetrics LLC, 
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Carlsbad, CA, USA), in sterile cryovials. 1-2 mL saliva were collected at least 2 hours 
after eating or drinking, kept at room temperature and processed immediately or within 2 
hours from collection. Recurring samples were collected from the same donors as needed 
for individual experiments. Gingival crevicular fluid from patients with periodontitis was 
collected from affected teeth using sterile endodontic paper points that were placed 
immediately in sterile vials with 1 mL reduced dental transport media (Anaerobe Systems, 
Morgan Hill, CA, USA), transported to the lab and further processed within 24 hours. 
Patients with periodontitis were sampled once.  
Oral microbiota samples were diluted 1:5 in dental transport media (L-1 distilled 
water): Na thioglycollate 1.0 g, Na2HPO4 1.15 g, NaCl  3.0 g, KCl 0.2 g, KH2PO4 0.2g, 
MgSO4 x 7H2O 0.1 g, L-cysteine HCl 0.5g, pH 7.3), mixed by vortexing for 1 minute then 
centrifuged at 1000 x g for 2 minutes to remove large particles. The supernatant was 
passed through 10-m CellTrics filters (Sysmex, USA) and the cells were collected by 
centrifugation (12,000 x g for 15 minutes), followed by resuspension in 1 ml PBS. An 
aliquot was used for total bacterial DNA extraction using proteinase K digestion and 
phenol-chloroform extraction (164). For fixation, an aliquot was fixed by addition of an 
equal volume of ice cold, 100% ethanol and stored at -20oC overnight. For live cell sorting, 
the processed microbiota samples were used immediately.   
TM7a genome mining, epitope selection and antibody generation. For 
selection of candidate proteins to serve as immunogens, we used the single cell genomic 
data generated by Marcy et al. (28), the only oral TM7 genomes available at the time we 
initiated this work. We used the TM7a (6806 protein genes) and TM7c datasets (590 
protein genes), based on the annotations available in IMG (https://img.jgi.doe.gov)(223), 
with the expectation that some of the genes may represent organisms other than TM7 
(44). We first selected genes encoding proteins associated with membrane processes, 
based on COG categories (transport functions, cell wall/membrane/envelope biogenesis, 
extracellular structures), using the IMG assignments. The corresponding proteins were 
analyzed for the presence of transmembrane anchoring helical domains using TMHMM 
v.2.0 (224). From the list of proteins with such domains, we eliminated the ones annotated 
as hypothetical as well as those shorter than 100 amino acids, as we aimed for final 
selection of relatively large proteins with known function. The proteins that passed those 
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criteria (117 combined between TM7a and TM7c) were analyzed by blastp against the 
proteomes of all oral bacteria downloaded from the Human Oral Microbiome Database 
(http://www.homd.org/). Forty eight of the proteins had high sequence similarity (>90%) 
to proteins from species of Leptotrichia (Fusobacteria), indicating they are likely 
contaminants, as previously reported (44).  We then individually analyzed the remaining 
sequences for number of transmembrane domains, number and size of predicted 
extracellular domains, availability of three-dimensional structures for homologues from 
other bacteria, and experimental data related to abundance or prior use as immunogens. 
The top pick was penicillin-binding protein 2 (PBP2), which belongs to a class of proteins 
with important roles in bacterial peptidoglycan synthesis (225). Both high resolution 
crystal structure data (210) and multiple reports that anti-PBP2 antibodies can bind to the 
cell surface of pathogenic bacteria (226, 227) were available. The closest homologues to 
the TM7a PBP2 present in genomes of human oral bacteria had 30-40% pairwise 
sequence identity (species of Selenomonas, Leptotrichia, Fusobacterium, 
Streptococcus). To test the applicability of the approach with a protein for which 3D 
structure or antigenic data were not available, we also selected CpsC as a target, as 
cellular studies indicated a cell surface-exposed domain (228, 229). CpsC belongs to the 
polysaccharide co-polymerases (PCPs) superfamily and is involved in capsular 
polysaccharide biosynthesis (230). We found no homologues in the oral bacterial 
genomes with a pairwise identity to TM7a CpsC over 30%.    
For selecting peptides to serve as antigens, we analyzed the two protein 
sequences for antigenic regions and peptide hydrophilicity using the online servers 
ABCpred (231), BepiPred (232), IEBD Analysis Resource 
(http://tools.immuneepitope.org/bcell) and Bio-Synthesis peptide design tools 
(https://www.biosyn.com), using a 16-18 amino acid-peptide threshold. We used Bio-
Synthesis (Lewisville, TX, USA) for peptide synthesis and antibody production. For PBP2, 
we identified 7 peptides that could serve as antigens and for CpsC we identified four 
peptides (Figure A4.1). We next analyzed the location of the 7 peptides from TM7a on 
the 3D structure of the protein based on the homologous regions of the E. coli PBPB 
structure (PDB 3vma) using PyMOL (https://pymol.org/2/). Further details on structural 
modeling and visualization are presented in the comparative structural analysis section. 
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The selected antigen peptide (SGNIKYAKQRQKTVLTRMV) was one of the three 
peptides with the most exposed residues. In the case of CpsC, because no experimental 
3D structure was available, we selected an antigenic peptide (ESAIQEFKEQSKSLYGNS) 
that is in a helical region of the predicted extracellular domain (Figure A4.1). 
The two selected peptides were commercially synthesized by Bio-Synthesis 
(Lewisville, TX, USA), with cysteine added at N (CpsC) or C terminus (PBP2), purified 
and injected in rabbits. For antisera production, Bio-Synthesis used a 70-day protocol, 
with 5 booster doses and 4 test bleeds followed by ELISA. We received serum batches 
confirmed by ELISA to be reactive against the antigenic peptides. For IgG purification we 
used HiTrap Protein A HP antibody purification columns (GE Bio-Sciences (Pittsburgh, 
PA, USA) according to manufacturer’s protocol. For fluorescent IgG labelling of 100 g 
IgG aliquots we used the Alexa Fluor™ 488 Antibody Labeling Kit from ThermoFisher 
(A20181) according to manufacturer’s instructions.  
Immunofluorescent labeling of oral microbiota samples and flow cytometry. 
Aliquots of oral microbiota samples, processed as described above and suspended in 
PBS were blocked for 30 minutes with 5% goat serum and a mixture of IgGs (1 g/mL 
each rabbit anti-Ignicoccus IgG (233), anti-Clostridium IgG (234) and human IgG, I4506, 
Sigma, St. Louis MO, USA) for blocking potential non-specific antibody-binding sites on 
some oral bacteria. We also used 5% rabbit pre-bleed serum instead of the goat serum, 
with no observed differences. Following blocking, fluorescently labelled anti-PBP2 or anti-
CpsC IgG were added to the samples at 0.1-1 g/mL. It was important to centrifuge the 
antibody solution (15,000 x g for 5 minutes) and carefully recover supernatant, prior to 
addition to the microbiota samples in order to reduce the background of fluorescent 
particles. Antibody labelling was conducted for 1 hour at room temperature, followed by 
either centrifugation (12,000 x g for 15 minutes) and resuspension in 2 mL PBS 
supplemented with 1% serum or directly diluting in 2 ml PBS with 1% serum (mainly for 
live cell sorting for cultivation experiments). After 30 minutes, the samples were analyzed 
by flow cytometry. Negative controls included unstained oral sample (to check for auto-
fluorescence), and samples processed in parallel with the oral sample but without 
microbiota (to check for fluorescent antibody precipitates).  
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For flow cytometry and cell sorting, we used a Cytopeia/BD Influx Model 208S 
(Cytopeia, Seattle, now BD, San Jose, CA), in a biological safety cabinet (BSC) designed 
specifically for the Influx cell sorter (Baker Co). Preparation of the flow cytometer for single 
cell sorting for genomic amplification and sequencing was as we and other have 
previously described (33, 235, 236).  For sorting, we used a 70-m nozzle and the 488-
nm laser for forward-side scatter (FSC-SSC) analyses as well as fluorescence detection 
and cell sorting trigger. Gating parameters were selected based on FSC-SSC and 
fluoresce levels for each experiment and sample. A very low level of highly 
autofluorescent particles (<0.01%, RFU>103) were observed in all samples in the 
absence of staining with the antibody and gating parameters were set to avoid sorting 
such particles. For genomic and community diversity analyses single or pools of 
fluorescent particles were deposited in 3 μL of DNA-free, Tris–HCl (10mM pH 8.0), 1mM 
EDTA (TE) in individual wells of 96 well plates. We observed sufficient fluorescence signal 
with primary labelled antibody preparations. However, if the signal would be low, using a 
secondary labelled antibody (e.g. goat anti-rabbit IgG) would provide signal amplification.  
Isolation and cultivation of oral TM7 bacteria. For cultivation, we used saliva 
samples collected recurrently from three healthy donors and processed them as detailed 
above. Antibody staining was performed as already described. For the initial cultivation 
tests, in 200 L liquid media in 96-well plates, we used as basal media commercial or 
home-made brain heart infusion (BHI, Difco), Oral Treponeme Enrichment Broth (OTEB, 
Anaerobe Systems, Morgan Hill, CA, USA), MTGE Broth (Anaerobe Systems), Tryptic 
Soy broth (TSB, Difco) supplemented with various additional factors (ATCC vitamins, 
trace minerals, clarified filtered saliva, pig gastric mucin, sugars, amino acids and 
nucleobases, N-acetyl muramic acid, N-acetyl glucosamine, pyruvate). Following flow 
sorting, performed as already described, the plates were incubated in an anaerobic 
chamber (COY, Grass Lake, MI, USA) at 37oC, under 85%N2, 10%CO2, 5%H2 or in 
anaerobic jars to which we added air via a syringe port to reach 2% O2. To test for TM7 
growth, after 48-72 hours we retrieved 100 l culture using multichannel pipettes and 
vacuum-filtered through 0.2 m filter 96-well plates (Millipore, Burlington MA, USA). The 
cells were washed with 200 L PBS. Then, 20 L TE were added to the filter. The plate 
was placed on an orbital shaker at 100 rpm for 5 minutes at room temperature. 10 L of 
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the cell suspension was then recovered in 96 well PCR plates, to which we added 10L 
lysis solution (0.13 M KOH, 3.3 mM EDTA pH 8.0). The plate was covered with adhesive 
foil and heated in a PCR machine at 95C for 5 min. The plate was immediately cooled 
on ice after which, 10 L neutralization buffer (0.13M HCl, 0.42M Tris pH 7.0, 0.18M Tris 
8.0) was added. We then used 1.5-2 L of the lysate in PCR reactions with universal and 
TM7 primers, as detailed earlier. The presence of TM7 in PCR positive cultures were 
further confirmed by Sanger sequencing and the cultures were transferred into fresh 
medium under the original growth conditions. We initially obtained TM7 positive cultures 
using BHI, OTEB, MTGE and TSB, primarily under microaerobic conditions. In liquid 
microcultures, in addition to TM7 HOT352 (Group 1), we also identified TM7 HOT347 
(Group 1) and HOT870 (Group 6).  However, none of positive microcultures were pure 
and contained various other bacteria (Streptococcus, Fusobacterium, Campylobacter, 
Actinomyces, Propionibacterium and Veillonella). While TM7 survived in those liquid 
cultures for several passages, we have not identified the hosts for HOT347 and HOT870. 
Because liquid cultures in 96 well plates were difficult to monitor and to prevent 
overgrowth, we used cell deposition and cultivation on solid media for final isolation 
experiments.  
For cultivation on solid medium we used DMM-agar (237) supplemented with 2% 
glucose, 0.1g/L casamino acids and 10% sheep blood as well as  BHI-agar supplemented 
with 10% sheep blood. Single cells were deposited by flow sorting in a 10x10 array on 
each plate, followed by incubation at 37oC under anaerobic or microaerobic conditions. 
Visible colonies formed after 3-5 days of incubation (Figure A4.3) were sampled with 
sterile tips and analyzed by direct PCR using primers 27FM-510R (TM7 specific) and 
27FM-1492R (universal bacteria). Secondary screening for TM7 bacteria was also 
performed using primers 910F (5’CATAAAGGAATTGACGGGGAC 3’) and 1177R (5’-
GACATCATCCCCTCCTTCC-3’) under the conditions 95°C for 2 minutes, 32-34 cycles 
of 95°C for 30 seconds, 61°C for 30 seconds, 72°C for 1 minute, followed by 72°C for 5 
minutes. Single band products were directly sequenced at Eurofins Genomics (Louisville, 
KY, USA) using Sanger chemistry. For colonies that contained other bacteria 
(Streptococcus, Veilonella), the original TM7-positive colony was repeatedly streaked on 
fresh plates until colonies containing only TM7 and a host actinobacterium were obtained. 
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For TM7 HOT346, a pure co-culture with Cellulosimicrobium cellulans was obtained 
following a second round of antibody staining and sorting (Figure A4.3). TM7 
enrichments and co-cultures with hosts could be maintained as freezer stocks in media 
containing 10% DMSO at -80°C. For further physiological characterization of TM7 
metabolism potential we supplemented solid (with 10% blood) and liquid (without blood) 
BHI media with 2-5mM of ribose, lactate, pyruvate, or phosphoenolpyruvate at 37°C or 
39°C in duplicate and screened for TM7 relative abundance after 2 and 5 days of 
incubation and a subsequent passage in the same media, as described above. Compared 
to a BHI only control, no significant differences were observed. 
For microscopic characterization of co-cultures, cells were fixed in 50% ethanol-
PBS overnight at -20°C. For fluorescence in situ hybridization we used cell immobilization 
and dehydration on gelatin-coated slides as described (238), with 30% formamide in the 
hybridization buffer. The probes we used were EUB338 
(5’GCTGCCTCCCGTAGGAGT3’) (universal bacteria), labeled with Alexa536 or 
Alexa647 and TM7-567 (5’CCTACGCAACTCTTTACGCC3’) labeled with Alexa488. In 
some experiments we also labelled cells with CellBrite Fix 640 Membrane Stain (Biotium) 
prior to fixation. Following hybridization and washing, the slides were covered with 
EverBrite Mounting Medium (Biotium) and analyzed by epifluorescence microscopy using 
a Zeiss AxioImager microscope. Color photographs were taken using a Canon 7D digital 
SLR and were merged in Adobe Photoshop. For immunofluorescence microscopy, in 
addition to the anti-PBP2-CspC antibody mix (labelled with Alexa 488), we also used a 
broad anti-Actinomyces rat IgG, generated by immunizing rats with a mix of Actinomyces 
species (A. odontoliticus, A. israelii, A. naeslundii, A. gerencseriae) and labeled with 
Alexa 647. The slides were first blocked with the same cocktail used in antibody staining 
for flow cytometry and stained with a mix of anti-PBP2-CspC and anti-Actinomyces 
antibodies for 60 minutes. After washing with PBS five times, the slides were mounted 
and visualized as above.  
Genomic amplification, taxonomic analysis and single cell genome 
sequencing. Sorted single cells or cell pools were stored frozen at -80oC until genomic 
DNA amplification. For amplification by MDA we used a protocol that we and others have 
described in detail previously (33, 235, 236). Single cells amplified genomes (SAGs) were 
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screened for the presence of TM7 by PCR using the primers 27FM 
(5’AGAGTTTGATYMTGGCTCAG-3’) and 510R (5’-CTCTTTACGCCCAGTCAC-3’) by 
denaturation at 94°C for 3 minutes followed by 32 cycles of amplification (95°C for 30 
seconds, 62°C for 30 seconds, 72°C for 30 seconds) and a final extension at 72°C for 5 
minutes. PCR products were sequenced on an ABI3730 DNA Analyzer (Applied 
Biosystems), at the University of Tennessee Sequencing Facility or at Eurofins Genomics 
(Louisville, KY, USA), using the same primers. Resulting chromatograms were manually 
edited for low quality regions using Geneious (https://www.geneious.com/) and 
sequences were used for phylogenetic identifications using the HOMD SSU rRNA 
database (http://www.homd.org/). Samples for which the chromatograms were not 
homogeneous and that denoted potential heterogeneous template DNA (more than one 
sorted cell) were not further used. While a mixed chromatogram may indicate the 
presence of a symbiont of TM7, because they could not be unambiguously distinguished 
from either DNA contamination or non-specifically adherent cells co-sorted with TM7, so 
we did not pursue characterization of mixed SAGs.  
To characterize the microbial diversity in cell populations sorted following antibody 
staining (10-100 cells), genomic amplification by MDA was conducted the same way as 
for single cells. The amplification product was first purified using a Zymo genomic DNA 
cleanup kit (Zymo Research, Irvine CA, USA). To determine the microbial composition of 
the original oral microbiota samples we used gDNA purified from the saliva and the 
subgingival samples. Microbial diversity was determined by amplification of the 
hypervariable V4 region of SSU rRNA gene followed by MiSeq amplicon sequencing. We 
followed the protocol described by Lundberg et al. (239), with a modification in the 
universal primers. Specifically, because the canonical 515F primer sequence 
(5’GTGCCAGCMGCCGCGGTAA) does not recognize TM7 rRNA, we supplemented the 
PCR reaction mix with 5% of a 515F-derivative that can bind TM7 rRNA 
(5’GTGCCAGCMGCCGCGGTCA). The reverse primer, 806R 
(5’GGACTACHVGGGTWTCTAAT) can recognize the full diversity of oral bacterial SSU 
rRNA. The purified amplicons were sequenced on the MiSeq platform (Illumina, San 
Diego CA, USA) on v2 or v3 sequencing chips using 2x250 nt reads. Read processing 
and microbial diversity analysis was performed using the software programs cutadapt 
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(240), usearch (241) and QIIME (242) as well as the HOMD SSU rRNA taxonomy 
database and following the commands and parameters listed in the “MySeq sequence 
analysis” supplementary file. To determine if the 254 nt V4 amplicon provides sufficient 
resolution to enable distinguishing the different human oral TM7 phylotypes, we 
determined the pairwise sequence identity between the 13 main types of oral TM7 OTUs 
and performed phylogenetic analysis including the TM7 OTUs identified based on 
sequencing the V4 amplicon (TM7HOTs_OTUs V4.fasta supplementary file).  As shown 
in Figure A4.2, with the exception of 2 OTU pairs (HOT346-HOT869 and HOT352-
HOT952), all other TM7 could be readily distinguished in MiSeq amplicons, with pairwise 
identity values bellow 98% and sufficient phylogenetic resolution.  
Purified DNAs of TM7 SAGs selected for genomic sequencing were used to 
generate libraries and were sequenced on Illumina HiSeq (100 nt paired reads) at the 
Hudson Alpha Institute for Biotechnology (Huntsville, AL, USA) or on MiSeq (250 nt paired 
reads) at ORNL. Approximately 100 million reads were obtained for each SAG sequenced 
on HiSeq and 10 million for the MiSeq SAGs.  
SAG assembly, annotation and comparative genomic analysis. For individual 
assembly, the reads for each SAG were trimmed using Trim Galore 0.4 
(https://github.com/FelixKrueger/TrimGalore) and assembled using SPADES 
(v3.9.0)(243). Removal of non-TM7 contigs (human and other bacterial sequences) was 
performed by a combination of GC-content-based binning, and Emergent Self-Organizing 
Maps (ESOM) based on kmer frequency (244). Further contamination was removed using 
DNA and protein BLAST and single-copy gene analysis (245, 246). Lastly, further 
assembly in Geneious (v8-10)(179) consolidated some contigs and the final cleaned 
genomes were analyzed with Prokka (v1.11)(247) for gene prediction and annotation. 
Completion and contamination estimates were calculated using CheckM (v1.0.11)(246) 
using the lineage workflow and a manually adapted gene-list workflow containing 42 
single copy genes conserved in CPR Bacteria (248) (Table S4.1, Figure A4.4). Pfam 
(v31)(249), eggNOG (v4.5.1)(128) and Interproscan (v5.27-66.0)(250) databases were 
used for protein assignment to families and orthologous groups. Anvi’o (v5.1) was used 
for core genome analysis and identification of conserved COGs following the 
pangenomics pipeline with mapping of eggNOGs (217, 218) (Table S4.1 and Figure 4.4). 
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NCBI, IMG and Geneious were used for basic homology searches and for obtaining 
genomic data for further metabolic inference analyses.  SSU rRNA and concatenated 
single-copy protein gene trees were generated in Geneious using RAxML, with estimation 
of all free parameters and 100 bootstraps (Figure A4.5). The TM7 SAGs sequences and 
associated metadata were deposited in Genbank under Bioproject PRJNA472398. SSU 
rRNA sequence alignments that include reference strains as well as detected phylotypes, 
SAGs and isolates obtained in this study are provided as supplemental files 
“TM7_16S.fasta” and “Actinomyces_16S.fasta”.  
Protein structure modeling. The glycosyltransferase domain of PBP2 from TM7a 
(residues 95-278) and TM7x (residues 145-334) was modeled using a combination of 
homology modeling and coevolution-based residue-residue contact prediction. We used 
the GREMLIN web server (251-253) to identify structural templates, predict residue 
contacts based on coevolution analysis, and generate contact restraints for Rosetta 
structural modeling (211). Briefly, the server uses HHblits (254) and to generate a multiple 
sequence alignment (MSA), which is then filtered to include only sequences that cover at 
least 75% of the query sequence, have fewer than 75% gaps, and have a maximum 
mutual sequence identity of 90%. From this MSA, GREMLIN learns a global statistical 
model that accounts for both sequence conservation and coevolution. Next, HHsearch 
(255) was used to identify potential templates for homology modeling from the Protein 
Data Bank (PDB)(256). More than 9,300 sequences of PBP2 homologs were identified 
from the sequence database search. For the ~190 residue proteins this number 
corresponds to a sequence/length ratio of ~51, indicating the robustness of the predicted 
residue contacts.  
For both TM7a and TM7x, the following five templates identified by HHsearch were 
used as templates for modeling PBP2: 3VMA (257), which is missing part of jaw 
subdomain, 3UDF (258) (also missing the jaw subdomain), 2OQO (259), 2OLV (210), 
and 3VMT(260) (Figure A4.7). Although multiple template structures are available, we 
included coevolution information to provide additional benefits compared to standard 
homology modeling. We used map_align (https://github.com/gjoni/map_align) to align the 
contact maps predicted from the coevolution analysis to selected templates identified by 
HHsearch. The initial threaded models generated by map_align were then used as input 
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for Rosetta hybrid modeling, and all models were given weights of 1.0. Fragment files 
were obtained with the Robetta server (261). We generated 10,000 models with both 
sigmoidal and bounded restraints during coarse-grained sampling and only sigmoidal 
restraints during full-atom refinement (253). Models were ranked on the basis of the sum 
of their Rosetta energy and the restraint score. The final models are shown in Figure 
A4.7. PyMOL (https://pymol.org/2/) and pdb format files of the models are also provided 
as supplementary data (PBP_structural_alignment.pse, tm7a_S_0876_ma1.1.pdb and 
tm7x_S_0959_ma1.5.pdb).  
CpsC (residues 1-197) was modeled with Rosetta using coevolution-derived 
residue-residue contact restraints. More than 3,700 sequences obtained with the 
GREMLIN webserver were used to perform the coevolution analysis. A PyMOL file of the 
3D model structure is provided as supplementary data (cpsc_epitope.pse).  
We analyzed the SAGs for the presence of the genes encoding the two proteins 
used as epitopes for raising antibodies. For PBP2, we found the gene in SAGs 
representing all of the TM7 lineages isolated by antibody capture. For Cbp2, we found 
the gene in only three of the lineages. This gene is also missing in the complete genome 
of TM7x, so the Cbp2 protein is not present across all TM7. The level of sequence 
similarity at the epitopes level varied between the different TM7 as compared to the 
original TM7a sequence but there were multiple conserved amino acids across all 
lineages. To better understand the structural basis of epitope recognition in the different 
TM7 PBP2, we modeled the three-dimensional structure of the TM7a/HOT348 and 
TM7x/HOT952 proteins based on crystal structures available for several homologues 
(Figure A4.7). In addition to structural templates, we included coevolutionary information 
in the form of residue-residue contacts (252) predicted from a deep multiple sequence 
alignment to improve the structural models. Because we were primarily interested in 
identifying structural determinants of epitope recognition, we generated structural models 
only of the extracellular, N-terminal glycosyltransferase domain (residues 95-278 in the 
TM7a PBP2 sequence). The final models share a similar overall fold and structure 
between TM7a and TM7x PBP2 even though they are only 37% identical. The -helix 
containing most of the epitope is located on the surface of the protein, with some of the 
conserved residues buried and others exposed or partially exposed (Figure 4.1b).  A 
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similar epitope topology was observed in the Cbp2 protein model (Figure 4.1c). The 
exposed residues include multiple polar and charged amino acids, which may be 
responsible for antibody recognition and binding. It is important to note that although the 
sequence similarity in the epitope region is as low as 35-50 % across the TM7 lineages, 
IgG variants were able to bind their target on the cell surface. Although the specificity 
breadth cannot be predicted, especially when only a single target sequence is available 
(as was the case with TM7a), polyclonal antibodies can therefore recognize multiple 
related species and increase the diversity in targeted isolation of microbial cells. Broader 
specificity can also result in cross reactivity with more distant, non-target organisms, 
potentially explaining some of the additional taxa we observed in pooled cell populations. 
           Data Availability.  Curated TM7 SAG sequences were deposited in GenBank 
under the Bioproject PRJNA472398. Aligned SSU rRNA sequences are provided as 
supplementary files. Raw sequence datafiles are available from the authors upon request.  
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Figure A4.1. Antigenic peptide selection. a. Alignment of TM7a PBP2 with the E. coli 
homologue based on 3D structure (3vma). Alpha helices are in red, beta sheets are 
shown as green arrows. The location of the predicted antigenic peptides (epitope 1-7) are 
in gray, and the selected epitope for antibody production is in blue. Three-dimensional 
structure (3vma) on the right shows the location of epitopes 2, 5 (selected), and 7 in gold 
color. b. Predicted secondary structure and topology of TM7a CpsC. The four predicted 





Figure A4.2. SSU rRNA V4 taxonomic resolution. a. Phylogenetic tree (Jukes Cantor-
corrected distances) of human oral TM7 reference sequences (HOTs) and MiSeq OTUs. 
Most OTUs can be unambiguously assigned to known HOT types. b. Pairwise identity 






Figure A4.3. TM7-host colonies following single cell sorting and incubation at 37C. a. 
Cells from primary TM7 HOT346-348 colony were re-stained with the antibody and b. 
sorted based on the gate shown in the flowgram on BHI-blood agar plate. The circled 
colonies contained a pure TM7 HOT346-Cellulosimicrobium co-culture. c. Primary colony 
of pure TM7 HOT351-Actinomyces sp. HOT897 co-culture. d. Primary colony of TM7 









Figure A4.4. Completion level and contamination analysis of oral TM7 SAGs. Analysis 
was based on CheckM using 42 single copy genes conserved in bacteria from the 
“Candidate Phyla Radiation”. Four closed TM7 genomes (TM7x, RAAC3, GWC2, and S. 
aalborgensis) were also analyzed for comparison. Each row represents a genome with 
colored bars representing the presence/absence/copies of single-copy genes. SAGs are 





Figure A4.5. Maximum likelihood phylogeny of concatenated proteins from TM7 bacteria 
based on SAGs, MAGs, and TM7x. SAGs in red were sequenced as part of this study. 
Other host-associated TM7 are indicated by gray dots. Black dots at nodes indicate 
bootstrap support >80, white circles are support values of 50-80%. Scale bar is inferred 






Figure A4.6. Abundance of COG categories between environmental and human oral 














Figure A4.7. Structure modeling of TM7 PBP. a. Structural templates for the GT domain 
of PBP2 from TM7a and TM7x identified by HHsearch. b. Target sequences for structural 
modeling. Structural models of PBP2 were generated for the regions in black text. The 
epitope region in TM7a is boxed. c. Final models of the glycosyltransferase domain of 
PBP2 form TM7a (left) and TM7x (right). Residue contacts predicted from coevolution 
analysis are shown as yellow lines. The models of the GT domain satisfy the coevolution 







































Periodontitis is the leading cause of tooth loss worldwide and is hypothesized to 
contribute to systemic diseases such as cardiovascular disease and irritable bowel 
disease (20, 74, 262). With over 770 species level bacterial taxa identified in the human 
oral cavity, approximately 1/3rd represent uncultivated members (12, 13), their 
recalcitrance may be due to dependencies on co-evolving bacterial community members 
yet identified. Some of the periodontal pathobionts have been recognized but many 
disease-associated lineages remain uncultured (17). Isolation and cultivation of these 
disease-associated microorganisms is essential to fully understand their role in disease. 
Isolation allows us to move away from just mere correlation with disease to direct 
causation so that we can begin to piece together an appropriate model for how such 
microbiome-associated diseases are acquired. Additionally, discovering new information 
about these organisms would allow for the development of innovative treatments and 
possible means of prevention for periodontitis. This dissertation takes a dual approach 
towards elucidating novel disease-associated lineages of bacteria in the human oral 
cavity using cultivation-dependent and -independent approaches (Figure 1.1). 
Sulfate-reducing bacteria (SRB) have been detected in periodontal pockets (55) 
and culture-independent studies have linked the SRB genus Desulfobulbus with 
progressive periodontal disease in the oral cavity (58, 59). Single-cell genomic analysis 
was able to probe the initial functions of the little known Desulfobulbus genus in the 
human oral cavity (33), but without a cultured representative, truly understanding the role 
of this organism in the microbial community remains difficult. Chapter 2 describes the 
isolation and characterization of the first species of the Desulfobulbus genus from the 
human oral cavity. With collaborators from the Ohio State College of Dentistry, we 
received human periodontal samples and enriched for SRB and isolated Desulfobulbus 
oralis sp. nov. In working towards the isolation of D. oralis, we obtained a stable co-culture 
of D. oralis and Fusobacterium nucleatum, another native oral microbial species. Further 
physiological characterization identified that D. oralis required by-products produced by 
F. nucleatum for growth in pure culture to occur (186). D. oralis is the first human-
associated representative of its genus and has provided unique insights into the genomic 
and physiological changes that have occurred as D. oralis co-evolved with its human host 
and to the emergence of pathogenicity. In addition to limited metabolic versatility and 
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niche specialization, we identified horizontal gene acquisitions from other oral microbiome 
members, such as toxins like leukotoxin and hemolysins, that can potentially trigger a 
proinflammatory response in oral epithelial cells. We showed that D. oralis is not merely 
a passive by-stander in disease progression but may actively contribute to disease 
etiology. This relationship could only be understood after isolation. 
Furthermore, understanding the relationship between D. oralis and F. nucleatum 
will provide useful insights to aid in the cultivation of more disease-associated bacterial 
lineages. Other oral microorganisms are dependent on F. nucleatum for growth (39, 40) 
but it remains unknown what molecules produced by F. nucleatum stimulate growth 
Preliminary tests with defined additions of amino acids, vitamins, siderophores, and 
complex nutrients did not alleviate the dependency of D. oralis for F. nucleatum filtrate. 
Additionally, the growth promoting component(s) of the F. nucleatum filtrate could not be 
inactivated with heating or protease treatment, suggesting it is not a protein but rather a 
small molecule(s) of some kind. Chapter 3 begins to elucidate the growth promoting 
characteristics of F. nucleatum using a metabolomics approach. Data analysis of mass 
spectrometry identified the metabolic by-products of F. nucleatum growth and we 
identified what F. nucleatum may be providing to stimulate D. oralis growth.  
As emphasized with the isolation of D. oralis, cultivation is ideally the ultimate goal 
to allow one to fully understand the repertoire of bacteria that make up the human 
microbiome and their roles in health and disease. However, a recent view of the tree of 
life has revealed an even more expansive assessment of bacterial lineages identifying 
entire phyla of currently uncultured organisms (27). Some of these lineages exist within 
the human oral microbiome (7). Specifically, one such phylum, the TM7 phylum 
(Candidate Division Saccharibacteria), has been recalcitrant to cultivation for many years 
with only one TM7 species, TM7x, isolated from the human oral cavity (45). Although the 
isolation of TM7x has significantly influenced our view of the oral microbiome, it is only 
one isolate of a large taxonomic diversity of TM7 bacteria in the oral cavity (29) and 
provides limited insight into the physiological diversification and roles these bacteria play 
there. Chapter 4 demonstrates a novel reverse-genomics approach using in-silico 
antibody design based on published sequencing data to target a wide diversity of TM7 
bacteria in the human oral cavity for genomics and cultivation. This method allows for 
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cultivation of bacteria who must also be co-isolated with their respective obligate bacterial 
hosts; a bottleneck that has resulted from classical cultivation techniques.  
We validate this with the cultivation of a previously uncultured lineage of TM7 
bacteria HOT351 and its formerly uncultured host, Actinomyces HOT897. In addition to 
live cultivation, we also sequenced twenty-three human oral TM7 single-cell genomes 
covering a large taxonomic diversity (eight unique OTUs) of the TM7 phylum in the oral 
cavity, the largest collection so far at the individual OTU level. Comparative genomics of 
this large dataset has provided a robust analysis of a core human oral TM7 genome and 
comparisons with free-living TM7 genomes has identified what traits may be important for 
human host-association. As compared to free-living TM7 relatives, human oral TM7 
bacteria are enriched for protein families of known virulence factors and novel viral 
defense mechanisms. 
Next-generation sequencing has greatly informed our understanding of the vast 
array of microorganisms on Earth however the limited number of cultured representatives 
of entire phyla still hinders our ability to truly understand the roles these organisms really 
play in their environments. Inferences can be made regarding their functions based on 
genomics and phylogenetic placement but without being able to test those hypotheses in 
the lab, sequencing remains merely hypothetical. The dual approach of my dissertation 
in leveraging next-generation sequencing analysis to bring disease-associated bacterial 
lineages into culture will uncover new information about not only individual 
microorganisms but how these organisms contribute to microbial community architecture 
and the specific interactions that may lead to dysbiosis and disease.   
Moving forward, figuring out the “mystery factor” that F. nucleatum is producing to 
stimulate growth of D. oralis is priority. To do so, one can utilize preparative HPLC to 
further fractionate the EtAc2 sample and continue to narrow in on what is in this 
supporting fraction. As it may be more than one compound working in synergy with 
hydroxybutyric acid, then this less complex fraction may be better resolved by LC-MS and 
NMR as GC-MS has limitations in the types of compounds that it can identify. Further, 
heavy labeled substrates (13C) can be purchased or synthesized of the identifying 
compounds and fed to D. oralis to determine whether or not these are actually being 
utilized by D. oralis. If some growth stimulation is occurring, then it may be a concentration 
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problem (either not enough or inhibitory concentrations of the target compound) that 
needs to be further investigated. Lastly, it would be interesting to test whether the final 
identified compound(s) can support growth of other oral bacteria that have been shown 
to be dependent on F. nucleatum for growth. 
Continued advancement and optimization of the “reverse genomics” is dually 
important. Culturing additional representatives of TM7 will uncover more information 
regarding host specificity and interactions. Likewise, expanding to environmental TM7 
and other (currently uncultured) lineages of bacteria, such as SR1 and GN02, can identify 
whether all CPR organisms have actinobacterial hosts in host-associated or free-living 
environments or have evolved separately with different hosts. Understanding the range 
of hosts can also aid in understanding limitations of host association (such as only Gram 
positive organisms capable of being hosts or in identifying shared features not present in 
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